| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | extracellular matrix structural constituent | COL4A4 FBLN1 THBS4 COL11A2 FBN1 FBN2 VCAN LAMB2 COL5A3 LTBP1 MUC6 FBN3 | 4.92e-11 | 188 | 90 | 12 | GO:0005201 |
| GeneOntologyMolecularFunction | ubiquitin-like ligase-substrate adaptor activity | DCAF13 PRAMEF5 PRAMEF9 PRAMEF15 PRAMEF4 PRAMEF27 PRAMEF11 PRAMEF6 | 3.37e-09 | 82 | 90 | 8 | GO:1990756 |
| GeneOntologyMolecularFunction | enzyme-substrate adaptor activity | DCAF13 PRAMEF5 PRAMEF9 PRAMEF15 PRAMEF4 PRAMEF27 PRAMEF11 PRAMEF6 | 1.09e-08 | 95 | 90 | 8 | GO:0140767 |
| GeneOntologyMolecularFunction | nuclear retinoic acid receptor binding | 1.72e-07 | 55 | 90 | 6 | GO:0042974 | |
| GeneOntologyMolecularFunction | high voltage-gated calcium channel activity | 3.73e-07 | 14 | 90 | 4 | GO:0008331 | |
| GeneOntologyMolecularFunction | aldehyde dehydrogenase (NAD+) activity | 5.07e-07 | 15 | 90 | 4 | GO:0004029 | |
| GeneOntologyMolecularFunction | low-density lipoprotein particle receptor activity | 6.74e-07 | 16 | 90 | 4 | GO:0005041 | |
| GeneOntologyMolecularFunction | aldehyde dehydrogenase [NAD(P)+] activity | 8.78e-07 | 17 | 90 | 4 | GO:0004030 | |
| GeneOntologyMolecularFunction | nuclear receptor binding | DCAF13 PRAMEF5 PRAMEF15 LRP2 PRAMEF4 PRAMEF27 PRAMEF11 PRAMEF6 | 2.05e-06 | 187 | 90 | 8 | GO:0016922 |
| GeneOntologyMolecularFunction | lipoprotein particle receptor activity | 2.18e-06 | 21 | 90 | 4 | GO:0030228 | |
| GeneOntologyMolecularFunction | calcium ion binding | FBLN1 THBS4 FBN1 FBN2 ITGB1BP2 VCAN LRP1 LRP2 DLK2 LTBP1 FBN3 ADGRL3 RYR2 LRP8 | 6.22e-06 | 749 | 90 | 14 | GO:0005509 |
| GeneOntologyMolecularFunction | structural molecule activity | COL4A4 FBLN1 CLDN11 THBS4 COL11A2 FBN1 FBN2 CRYGN VCAN LAMB2 COL5A3 LAMC3 LTBP1 MUC6 FBN3 | 9.84e-06 | 891 | 90 | 15 | GO:0005198 |
| GeneOntologyMolecularFunction | calcium channel activity | 2.58e-05 | 129 | 90 | 6 | GO:0005262 | |
| GeneOntologyMolecularFunction | voltage-gated calcium channel activity | 5.45e-05 | 46 | 90 | 4 | GO:0005245 | |
| GeneOntologyMolecularFunction | calcium ion transmembrane transporter activity | 6.25e-05 | 151 | 90 | 6 | GO:0015085 | |
| GeneOntologyMolecularFunction | oxidoreductase activity, acting on the aldehyde or oxo group of donors, NAD or NADP as acceptor | 6.45e-05 | 48 | 90 | 4 | GO:0016620 | |
| GeneOntologyMolecularFunction | RNA polymerase II-specific DNA-binding transcription factor binding | TTC8 DCAF13 PRAMEF5 PRAMEF15 LRP2 PRAMEF4 PRAMEF27 PRAMEF11 PRAMEF6 | 1.10e-04 | 417 | 90 | 9 | GO:0061629 |
| GeneOntologyMolecularFunction | oxidoreductase activity, acting on the aldehyde or oxo group of donors | 1.18e-04 | 56 | 90 | 4 | GO:0016903 | |
| GeneOntologyMolecularFunction | integrin binding | 1.41e-04 | 175 | 90 | 6 | GO:0005178 | |
| GeneOntologyMolecularFunction | olfactory receptor activity | 1.41e-04 | 431 | 90 | 9 | GO:0004984 | |
| GeneOntologyMolecularFunction | voltage-gated calcium channel activity involved in cardiac muscle cell action potential | 1.99e-04 | 5 | 90 | 2 | GO:0086007 | |
| GeneOntologyMolecularFunction | odorant binding | 2.74e-04 | 127 | 90 | 5 | GO:0005549 | |
| GeneOntologyMolecularFunction | transmembrane signaling receptor activity | NPC1 OR5W2 OR2B11 FCRL2 OR9G1 OR7C2 OR7C1 OR9G4 OR9Q2 TLR2 LTBP1 OR10T2 ADGRL3 OR9G9 LRP8 SORL1 | 3.28e-04 | 1353 | 90 | 16 | GO:0004888 |
| GeneOntologyMolecularFunction | 3-chloroallyl aldehyde dehydrogenase activity | 4.16e-04 | 7 | 90 | 2 | GO:0004028 | |
| GeneOntologyMolecularFunction | cargo receptor activity | 5.91e-04 | 85 | 90 | 4 | GO:0038024 | |
| GeneOntologyMolecularFunction | glyceraldehyde-3-phosphate dehydrogenase (NAD+) (non-phosphorylating) activity | 7.09e-04 | 9 | 90 | 2 | GO:0043878 | |
| GeneOntologyMolecularFunction | phosphatidylinositol-3,5-bisphosphate 3-phosphatase activity | 1.08e-03 | 11 | 90 | 2 | GO:0052629 | |
| GeneOntologyMolecularFunction | extracellular matrix structural constituent conferring tensile strength | 1.17e-03 | 46 | 90 | 3 | GO:0030020 | |
| GeneOntologyMolecularFunction | amyloid-beta binding | 1.17e-03 | 102 | 90 | 4 | GO:0001540 | |
| GeneOntologyMolecularFunction | DNA-binding transcription factor binding | TTC8 DCAF13 PRAMEF5 PRAMEF15 LRP2 PRAMEF4 PRAMEF27 PRAMEF11 PRAMEF6 | 1.24e-03 | 582 | 90 | 9 | GO:0140297 |
| GeneOntologyMolecularFunction | extracellular matrix constituent conferring elasticity | 1.29e-03 | 12 | 90 | 2 | GO:0030023 | |
| GeneOntologyMolecularFunction | glycosaminoglycan binding | 1.34e-03 | 268 | 90 | 6 | GO:0005539 | |
| GeneOntologyMolecularFunction | insulin-like growth factor I binding | 1.52e-03 | 13 | 90 | 2 | GO:0031994 | |
| GeneOntologyMolecularFunction | retinal dehydrogenase activity | 1.76e-03 | 14 | 90 | 2 | GO:0001758 | |
| GeneOntologyMolecularFunction | phosphatidylinositol-3-phosphate phosphatase activity | 1.76e-03 | 14 | 90 | 2 | GO:0004438 | |
| GeneOntologyMolecularFunction | structural molecule activity conferring elasticity | 1.76e-03 | 14 | 90 | 2 | GO:0097493 | |
| GeneOntologyMolecularFunction | phosphatidylinositol monophosphate phosphatase activity | 2.03e-03 | 15 | 90 | 2 | GO:0052744 | |
| GeneOntologyMolecularFunction | phosphatidylinositol-3,5-bisphosphate phosphatase activity | 2.31e-03 | 16 | 90 | 2 | GO:0106018 | |
| GeneOntologyMolecularFunction | molecular adaptor activity | COL4A4 FCRL2 COL11A2 DCAF13 PRAMEF5 PRAMEF9 PRAMEF15 LTBP1 PRAMEF4 SEPTIN10 PRAMEF27 SEPTIN6 PRAMEF11 PRAMEF6 | 2.90e-03 | 1356 | 90 | 14 | GO:0060090 |
| GeneOntologyMolecularFunction | insulin-like growth factor binding | 3.27e-03 | 19 | 90 | 2 | GO:0005520 | |
| GeneOntologyMolecularFunction | sulfur compound binding | 3.41e-03 | 323 | 90 | 6 | GO:1901681 | |
| GeneOntologyMolecularFunction | apolipoprotein binding | 3.62e-03 | 20 | 90 | 2 | GO:0034185 | |
| GeneOntologyMolecularFunction | NAD binding | 4.39e-03 | 73 | 90 | 3 | GO:0051287 | |
| GeneOntologyMolecularFunction | monoatomic cation channel activity | 4.57e-03 | 343 | 90 | 6 | GO:0005261 | |
| GeneOntologyMolecularFunction | voltage-gated monoatomic cation channel activity | 4.97e-03 | 152 | 90 | 4 | GO:0022843 | |
| GeneOntologyMolecularFunction | metal ion transmembrane transporter activity | 5.04e-03 | 465 | 90 | 7 | GO:0046873 | |
| GeneOntologyMolecularFunction | G protein-coupled receptor activity | OR5W2 OR2B11 OR9G1 OR7C2 OR7C1 OR9G4 OR9Q2 OR10T2 ADGRL3 OR9G9 | 6.40e-03 | 884 | 90 | 10 | GO:0004930 |
| GeneOntologyMolecularFunction | phosphatidylinositol bisphosphate phosphatase activity | 6.55e-03 | 27 | 90 | 2 | GO:0034593 | |
| GeneOntologyMolecularFunction | transcription factor binding | TTC8 DCAF13 PRAMEF5 PRAMEF15 LRP2 PRAMEF4 PRAMEF27 PRAMEF11 PRAMEF6 | 6.83e-03 | 753 | 90 | 9 | GO:0008134 |
| GeneOntologyMolecularFunction | phosphatidylinositol phosphate phosphatase activity | 8.05e-03 | 30 | 90 | 2 | GO:0052866 | |
| GeneOntologyMolecularFunction | alpha-actinin binding | 8.58e-03 | 31 | 90 | 2 | GO:0051393 | |
| GeneOntologyMolecularFunction | voltage-gated monoatomic ion channel activity | 9.29e-03 | 182 | 90 | 4 | GO:0005244 | |
| GeneOntologyMolecularFunction | voltage-gated channel activity | 9.64e-03 | 184 | 90 | 4 | GO:0022832 | |
| GeneOntologyBiologicalProcess | sensory perception | OR5W2 OR2B11 CACNA1D TTC8 CACNA1F COL11A2 OR9G1 OR7C2 OR7C1 CRYGN OR9G4 OR9Q2 TRPV2 LRP2 LAMB2 LAMC3 OR10T2 ABCC6 OR9G9 | 1.45e-07 | 1072 | 90 | 19 | GO:0007600 |
| GeneOntologyBiologicalProcess | sequestering of TGFbeta in extracellular matrix | 3.20e-07 | 4 | 90 | 3 | GO:0035583 | |
| GeneOntologyBiologicalProcess | calcium ion import across plasma membrane | 2.09e-06 | 48 | 90 | 5 | GO:0098703 | |
| GeneOntologyBiologicalProcess | calcium ion import into cytosol | 2.09e-06 | 48 | 90 | 5 | GO:1902656 | |
| GeneOntologyBiologicalProcess | retinoid metabolic process | 2.53e-06 | 89 | 90 | 6 | GO:0001523 | |
| GeneOntologyBiologicalProcess | diterpenoid metabolic process | 3.49e-06 | 94 | 90 | 6 | GO:0016101 | |
| GeneOntologyBiologicalProcess | maintenance of protein location in extracellular region | 4.43e-06 | 8 | 90 | 3 | GO:0071694 | |
| GeneOntologyBiologicalProcess | oocyte development | 4.72e-06 | 99 | 90 | 6 | GO:0048599 | |
| GeneOntologyBiologicalProcess | oocyte differentiation | 5.94e-06 | 103 | 90 | 6 | GO:0009994 | |
| GeneOntologyBiologicalProcess | terpenoid metabolic process | 6.64e-06 | 105 | 90 | 6 | GO:0006721 | |
| GeneOntologyBiologicalProcess | maintenance of location | 8.86e-06 | 396 | 90 | 10 | GO:0051235 | |
| GeneOntologyBiologicalProcess | sequestering of extracellular ligand from receptor | 1.29e-05 | 11 | 90 | 3 | GO:0035581 | |
| GeneOntologyBiologicalProcess | detection of chemical stimulus | OR5W2 OR2B11 OR9G1 OR7C2 OR7C1 OR9G4 OR9Q2 TLR2 OR10T2 RYR2 OR9G9 | 1.74e-05 | 524 | 90 | 11 | GO:0009593 |
| GeneOntologyBiologicalProcess | extracellular regulation of signal transduction | 2.23e-05 | 13 | 90 | 3 | GO:1900115 | |
| GeneOntologyBiologicalProcess | extracellular negative regulation of signal transduction | 2.23e-05 | 13 | 90 | 3 | GO:1900116 | |
| GeneOntologyBiologicalProcess | blastocyst formation | 2.32e-05 | 78 | 90 | 5 | GO:0001825 | |
| GeneOntologyBiologicalProcess | sensory perception of smell | OR5W2 OR2B11 TTC8 OR9G1 OR7C2 OR7C1 OR9G4 OR9Q2 OR10T2 OR9G9 | 3.52e-05 | 465 | 90 | 10 | GO:0007608 |
| GeneOntologyBiologicalProcess | isoprenoid metabolic process | 4.01e-05 | 144 | 90 | 6 | GO:0006720 | |
| GeneOntologyBiologicalProcess | regulation of ERK1 and ERK2 cascade | FBLN1 PRAMEF5 TLR2 PRAMEF15 LRP1 PRAMEF4 PRAMEF11 PRAMEF6 RIT2 | 4.67e-05 | 385 | 90 | 9 | GO:0070372 |
| GeneOntologyBiologicalProcess | import into cell | NPC1 ADM CACNA1C CACNA1D CACNA1F CACNA1S LIPA SYNGR3 TLR2 TRPV2 LRP1 LRP2 LRP8 SORL1 RIT2 | 5.92e-05 | 1074 | 90 | 15 | GO:0098657 |
| GeneOntologyBiologicalProcess | oogenesis | 6.27e-05 | 156 | 90 | 6 | GO:0048477 | |
| GeneOntologyBiologicalProcess | detection of stimulus | OR5W2 OR2B11 CACNA1F OR9G1 OR7C2 OR7C1 OR9G4 OR9Q2 TLR2 OR10T2 RYR2 OR9G9 | 6.94e-05 | 722 | 90 | 12 | GO:0051606 |
| GeneOntologyBiologicalProcess | calcium ion import | 6.98e-05 | 98 | 90 | 5 | GO:0070509 | |
| GeneOntologyBiologicalProcess | ERK1 and ERK2 cascade | FBLN1 PRAMEF5 TLR2 PRAMEF15 LRP1 PRAMEF4 PRAMEF11 PRAMEF6 RIT2 | 8.77e-05 | 418 | 90 | 9 | GO:0070371 |
| GeneOntologyBiologicalProcess | camera-type eye development | CACNA1C TTC8 CACNA1F CACNA1S ALDH1A2 CRYGN LAMB2 LAMC3 ALDH1A3 | 1.01e-04 | 426 | 90 | 9 | GO:0043010 |
| GeneOntologyBiologicalProcess | somatic stem cell population maintenance | 1.11e-04 | 108 | 90 | 5 | GO:0035019 | |
| GeneOntologyBiologicalProcess | detection of chemical stimulus involved in sensory perception of smell | 1.13e-04 | 432 | 90 | 9 | GO:0050911 | |
| GeneOntologyBiologicalProcess | maintenance of protein location | 1.31e-04 | 112 | 90 | 5 | GO:0045185 | |
| GeneOntologyBiologicalProcess | blastocyst development | 1.34e-04 | 179 | 90 | 6 | GO:0001824 | |
| GeneOntologyBiologicalProcess | sensory perception of chemical stimulus | OR5W2 OR2B11 TTC8 OR9G1 OR7C2 OR7C1 OR9G4 OR9Q2 OR10T2 OR9G9 | 1.35e-04 | 547 | 90 | 10 | GO:0007606 |
| GeneOntologyBiologicalProcess | positive regulation of lysosomal protein catabolic process | 1.87e-04 | 5 | 90 | 2 | GO:1905167 | |
| GeneOntologyBiologicalProcess | chemoattraction of axon | 1.87e-04 | 5 | 90 | 2 | GO:0061642 | |
| GeneOntologyBiologicalProcess | axon extension involved in regeneration | 1.87e-04 | 5 | 90 | 2 | GO:0048677 | |
| GeneOntologyBiologicalProcess | positive regulation of calcium ion transmembrane transport via high voltage-gated calcium channel | 1.87e-04 | 5 | 90 | 2 | GO:1904879 | |
| GeneOntologyBiologicalProcess | detection of stimulus involved in sensory perception | OR5W2 OR2B11 CACNA1F OR9G1 OR7C2 OR7C1 OR9G4 OR9Q2 OR10T2 OR9G9 | 2.23e-04 | 582 | 90 | 10 | GO:0050906 |
| GeneOntologyBiologicalProcess | eye development | CACNA1C TTC8 CACNA1F CACNA1S ALDH1A2 CRYGN LAMB2 LAMC3 ALDH1A3 | 2.47e-04 | 480 | 90 | 9 | GO:0001654 |
| GeneOntologyBiologicalProcess | visual system development | CACNA1C TTC8 CACNA1F CACNA1S ALDH1A2 CRYGN LAMB2 LAMC3 ALDH1A3 | 2.59e-04 | 483 | 90 | 9 | GO:0150063 |
| GeneOntologyBiologicalProcess | detection of chemical stimulus involved in sensory perception | 2.67e-04 | 485 | 90 | 9 | GO:0050907 | |
| GeneOntologyBiologicalProcess | sprouting of injured axon | 2.79e-04 | 6 | 90 | 2 | GO:0048682 | |
| GeneOntologyBiologicalProcess | regulation of phosphatidylinositol dephosphorylation | 2.79e-04 | 6 | 90 | 2 | GO:0060304 | |
| GeneOntologyBiologicalProcess | sensory system development | CACNA1C TTC8 CACNA1F CACNA1S ALDH1A2 CRYGN LAMB2 LAMC3 ALDH1A3 | 2.92e-04 | 491 | 90 | 9 | GO:0048880 |
| GeneOntologyBiologicalProcess | G protein-coupled receptor signaling pathway | OR5W2 ADM OR2B11 CACNA1D OR9G1 OR7C2 OR7C1 OR9G4 OR9Q2 LRP1 PDE10A OR10T2 ADGRL3 OR9G9 SORL1 RIT2 | 3.22e-04 | 1395 | 90 | 16 | GO:0007186 |
| GeneOntologyBiologicalProcess | calcium ion transmembrane import into cytosol | 3.78e-04 | 217 | 90 | 6 | GO:0097553 | |
| GeneOntologyBiologicalProcess | negative regulation of transmembrane receptor protein serine/threonine kinase signaling pathway | 3.87e-04 | 218 | 90 | 6 | GO:0090101 | |
| GeneOntologyBiologicalProcess | positive regulation of protein catabolic process in the vacuole | 3.90e-04 | 7 | 90 | 2 | GO:1904352 | |
| GeneOntologyBiologicalProcess | inorganic ion import across plasma membrane | 3.96e-04 | 142 | 90 | 5 | GO:0099587 | |
| GeneOntologyBiologicalProcess | inorganic cation import across plasma membrane | 3.96e-04 | 142 | 90 | 5 | GO:0098659 | |
| GeneOntologyBiologicalProcess | cell-cell signaling involved in cardiac conduction | 4.36e-04 | 34 | 90 | 3 | GO:0086019 | |
| GeneOntologyBiologicalProcess | female gamete generation | 4.37e-04 | 223 | 90 | 6 | GO:0007292 | |
| GeneOntologyBiologicalProcess | import across plasma membrane | 5.14e-04 | 230 | 90 | 6 | GO:0098739 | |
| GeneOntologyBiologicalProcess | stem cell population maintenance | 6.02e-04 | 237 | 90 | 6 | GO:0019827 | |
| GeneOntologyBiologicalProcess | positive regulation of cell population proliferation | ADM FBLN1 THBS4 ALDH1A2 PRAMEF25 PRAMEF5 PRAMEF9 VCAN PRAMEF15 LRP2 PRAMEF4 PRAMEF27 PRAMEF11 PRAMEF6 | 6.19e-04 | 1190 | 90 | 14 | GO:0008284 |
| GeneOntologyBiologicalProcess | glial cell development | 6.26e-04 | 157 | 90 | 5 | GO:0021782 | |
| GeneOntologyBiologicalProcess | gliogenesis | 6.29e-04 | 435 | 90 | 8 | GO:0042063 | |
| GeneOntologyBiologicalProcess | maintenance of cell number | 6.71e-04 | 242 | 90 | 6 | GO:0098727 | |
| GeneOntologyBiologicalProcess | aldehyde metabolic process | 7.97e-04 | 95 | 90 | 4 | GO:0006081 | |
| GeneOntologyBiologicalProcess | vitamin A metabolic process | 8.28e-04 | 10 | 90 | 2 | GO:0006776 | |
| GeneOntologyBiologicalProcess | SA node cell to atrial cardiac muscle cell signaling | 8.28e-04 | 10 | 90 | 2 | GO:0086018 | |
| GeneOntologyBiologicalProcess | SA node cell action potential | 8.28e-04 | 10 | 90 | 2 | GO:0086015 | |
| GeneOntologyBiologicalProcess | glomerular basement membrane development | 8.28e-04 | 10 | 90 | 2 | GO:0032836 | |
| GeneOntologyBiologicalProcess | cellular response to caffeine | 1.01e-03 | 11 | 90 | 2 | GO:0071313 | |
| GeneOntologyBiologicalProcess | SA node cell to atrial cardiac muscle cell communication | 1.01e-03 | 11 | 90 | 2 | GO:0086070 | |
| GeneOntologyBiologicalProcess | astrocyte development | 1.13e-03 | 47 | 90 | 3 | GO:0014002 | |
| GeneOntologyBiologicalProcess | animal organ morphogenesis | ADM TTC8 LIPA ALDH1A2 COL11A2 FBN2 KIF26B LRP2 LAMB2 LAMC3 ALDH1A3 ITGB4 RYR2 DNAH11 | 1.16e-03 | 1269 | 90 | 14 | GO:0009887 |
| GeneOntologyBiologicalProcess | regulation of lysosomal protein catabolic process | 1.21e-03 | 12 | 90 | 2 | GO:1905165 | |
| GeneOntologyBiologicalProcess | regulation of ventricular cardiac muscle cell action potential | 1.21e-03 | 12 | 90 | 2 | GO:0098911 | |
| GeneOntologyBiologicalProcess | AV node cell to bundle of His cell signaling | 1.21e-03 | 12 | 90 | 2 | GO:0086027 | |
| GeneOntologyBiologicalProcess | AV node cell action potential | 1.21e-03 | 12 | 90 | 2 | GO:0086016 | |
| GeneOntologyBiologicalProcess | negative regulation of apoptotic process | NPC1 PRAMEF25 PRAMEF5 PRAMEF9 PRAMEF15 LRP1 LRP2 G2E3 PRAMEF4 ALDH2 PRAMEF27 PRAMEF11 PRAMEF6 | 1.24e-03 | 1133 | 90 | 13 | GO:0043066 |
| GeneOntologyBiologicalProcess | extracellular matrix organization | 1.31e-03 | 377 | 90 | 7 | GO:0030198 | |
| GeneOntologyBiologicalProcess | extracellular structure organization | 1.33e-03 | 378 | 90 | 7 | GO:0043062 | |
| GeneOntologyBiologicalProcess | external encapsulating structure organization | 1.35e-03 | 379 | 90 | 7 | GO:0045229 | |
| GeneOntologyBiologicalProcess | carnitine metabolic process | 1.42e-03 | 13 | 90 | 2 | GO:0009437 | |
| GeneOntologyBiologicalProcess | fat-soluble vitamin metabolic process | 1.44e-03 | 51 | 90 | 3 | GO:0006775 | |
| GeneOntologyBiologicalProcess | renal system development | 1.50e-03 | 386 | 90 | 7 | GO:0072001 | |
| GeneOntologyBiologicalProcess | regulation of protein catabolic process in the vacuole | 1.66e-03 | 14 | 90 | 2 | GO:1904350 | |
| GeneOntologyBiologicalProcess | cellular response to purine-containing compound | 1.66e-03 | 14 | 90 | 2 | GO:0071415 | |
| GeneOntologyBiologicalProcess | retinoic acid biosynthetic process | 1.66e-03 | 14 | 90 | 2 | GO:0002138 | |
| GeneOntologyBiologicalProcess | negative regulation of programmed cell death | NPC1 PRAMEF25 PRAMEF5 PRAMEF9 PRAMEF15 LRP1 LRP2 G2E3 PRAMEF4 ALDH2 PRAMEF27 PRAMEF11 PRAMEF6 | 1.66e-03 | 1171 | 90 | 13 | GO:0043069 |
| GeneOntologyBiologicalProcess | heart development | 1.69e-03 | 757 | 90 | 10 | GO:0007507 | |
| GeneOntologyCellularComponent | Cul2-RING ubiquitin ligase complex | 1.49e-09 | 47 | 93 | 7 | GO:0031462 | |
| GeneOntologyCellularComponent | extracellular matrix | COL4A4 FBLN1 THBS4 COL11A2 FBN1 FBN2 VCAN LAMB2 COL5A3 LAMC3 LTBP1 ADAMTS14 ITGB4 MUC6 ANGPTL5 FBN3 | 2.98e-08 | 656 | 93 | 16 | GO:0031012 |
| GeneOntologyCellularComponent | external encapsulating structure | COL4A4 FBLN1 THBS4 COL11A2 FBN1 FBN2 VCAN LAMB2 COL5A3 LAMC3 LTBP1 ADAMTS14 ITGB4 MUC6 ANGPTL5 FBN3 | 3.11e-08 | 658 | 93 | 16 | GO:0030312 |
| GeneOntologyCellularComponent | microfibril | 2.55e-07 | 13 | 93 | 4 | GO:0001527 | |
| GeneOntologyCellularComponent | collagen-containing extracellular matrix | COL4A4 FBLN1 THBS4 COL11A2 FBN1 FBN2 VCAN LAMB2 COL5A3 LAMC3 LTBP1 ITGB4 ANGPTL5 | 6.30e-07 | 530 | 93 | 13 | GO:0062023 |
| GeneOntologyCellularComponent | basement membrane | 1.21e-06 | 122 | 93 | 7 | GO:0005604 | |
| GeneOntologyCellularComponent | cullin-RING ubiquitin ligase complex | DCAF13 PRAMEF5 PRAMEF9 PRAMEF15 PRAMEF4 PRAMEF27 PRAMEF11 PRAMEF6 | 4.77e-06 | 212 | 93 | 8 | GO:0031461 |
| GeneOntologyCellularComponent | L-type voltage-gated calcium channel complex | 1.82e-05 | 12 | 93 | 3 | GO:1990454 | |
| GeneOntologyCellularComponent | calcium channel complex | 1.85e-05 | 73 | 93 | 5 | GO:0034704 | |
| GeneOntologyCellularComponent | voltage-gated calcium channel complex | 5.19e-05 | 46 | 93 | 4 | GO:0005891 | |
| GeneOntologyCellularComponent | supramolecular polymer | COL4A4 CACNA1C CACNA1D CACNA1S FBLN1 CLDN11 COL11A2 FBN1 FBN2 KIF26B ITGB1BP2 COL5A3 LTBP1 FBN3 RYR2 DNAH11 | 6.41e-05 | 1187 | 93 | 16 | GO:0099081 |
| GeneOntologyCellularComponent | complex of collagen trimers | 1.07e-04 | 21 | 93 | 3 | GO:0098644 | |
| GeneOntologyCellularComponent | ubiquitin ligase complex | DCAF13 PRAMEF5 PRAMEF9 PRAMEF15 PRAMEF4 PRAMEF27 PRAMEF11 PRAMEF6 | 1.75e-04 | 352 | 93 | 8 | GO:0000151 |
| GeneOntologyCellularComponent | motile cilium | PRAMEF5 PRAMEF15 PRAMEF4 SEPTIN10 SEPTIN6 PRAMEF11 PRAMEF6 DNAH11 | 1.86e-04 | 355 | 93 | 8 | GO:0031514 |
| GeneOntologyCellularComponent | supramolecular fiber | CACNA1C CACNA1D CACNA1S FBLN1 CLDN11 COL11A2 FBN1 FBN2 KIF26B ITGB1BP2 COL5A3 LTBP1 FBN3 RYR2 DNAH11 | 2.10e-04 | 1179 | 93 | 15 | GO:0099512 |
| GeneOntologyCellularComponent | sperm annulus | 6.91e-04 | 9 | 93 | 2 | GO:0097227 | |
| GeneOntologyCellularComponent | endoplasmic reticulum lumen | 7.05e-04 | 332 | 93 | 7 | GO:0005788 | |
| GeneOntologyCellularComponent | I band | 8.80e-04 | 166 | 93 | 5 | GO:0031674 | |
| GeneOntologyCellularComponent | axonal growth cone | 1.06e-03 | 45 | 93 | 3 | GO:0044295 | |
| GeneOntologyCellularComponent | fibrillar collagen trimer | 1.26e-03 | 12 | 93 | 2 | GO:0005583 | |
| GeneOntologyCellularComponent | banded collagen fibril | 1.26e-03 | 12 | 93 | 2 | GO:0098643 | |
| GeneOntologyCellularComponent | septin complex | 1.72e-03 | 14 | 93 | 2 | GO:0031105 | |
| GeneOntologyCellularComponent | septin ring | 1.72e-03 | 14 | 93 | 2 | GO:0005940 | |
| GeneOntologyCellularComponent | cilium | TTC8 CACNA1F PRAMEF5 VCAN PRAMEF15 PRAMEF4 SEPTIN10 SEPTIN6 PRAMEF11 PRAMEF6 DNAH11 | 2.12e-03 | 898 | 93 | 11 | GO:0005929 |
| GeneOntologyCellularComponent | septin cytoskeleton | 2.26e-03 | 16 | 93 | 2 | GO:0032156 | |
| GeneOntologyCellularComponent | acrosomal vesicle | 2.28e-03 | 206 | 93 | 5 | GO:0001669 | |
| GeneOntologyCellularComponent | cell body | CACNA1C CACNA1D CACNA1F TLR2 TRPV2 LRP1 LTBP1 PDE10A LRP8 SORL1 RIT2 | 2.76e-03 | 929 | 93 | 11 | GO:0044297 |
| GeneOntologyCellularComponent | cation channel complex | 4.01e-03 | 235 | 93 | 5 | GO:0034703 | |
| GeneOntologyCellularComponent | Z disc | 4.64e-03 | 151 | 93 | 4 | GO:0030018 | |
| GeneOntologyCellularComponent | sarcomere | 5.11e-03 | 249 | 93 | 5 | GO:0030017 | |
| GeneOntologyCellularComponent | T-tubule | 5.28e-03 | 79 | 93 | 3 | GO:0030315 | |
| HumanPheno | Retinal detachment | 6.24e-06 | 118 | 32 | 7 | HP:0000541 | |
| MousePheno | abnormal jejunum morphology | 5.89e-08 | 41 | 72 | 6 | MP:0004002 | |
| MousePheno | abnormal spermatogonia proliferation | 1.37e-07 | 47 | 72 | 6 | MP:0002685 | |
| MousePheno | abnormal kidney morphology | ADM COL4A4 CACNA1C TTC8 FBLN1 LIPA ALDH1A2 PRAMEF5 FBN2 STAG1 KIF26B OR9G4 PRAMEF15 LRP2 LAMB2 G2E3 LTBP1 PRAMEF4 ZDHHC13 ABCC6 PRAMEF11 PRAMEF6 DNAH11 | 1.65e-07 | 1363 | 72 | 23 | MP:0002135 |
| MousePheno | abnormal heart size | ADM CACNA1C FBLN1 THBS4 ALDH1A2 FBN1 PRAMEF5 FBN2 KIF26B OR9G4 TLR2 PRAMEF15 LRP1 LRP2 G2E3 PRAMEF4 ALDH2 PRAMEF11 RYR2 PRAMEF6 DNAH11 | 2.81e-07 | 1180 | 72 | 21 | MP:0005406 |
| MousePheno | abnormal duodenum morphology | 8.94e-07 | 64 | 72 | 6 | MP:0003271 | |
| MousePheno | small kidney | COL4A4 CACNA1C ALDH1A2 PRAMEF5 STAG1 KIF26B OR9G4 PRAMEF15 G2E3 PRAMEF4 PRAMEF11 PRAMEF6 | 1.57e-06 | 425 | 72 | 12 | MP:0002989 |
| MousePheno | enlarged heart | ADM CACNA1C THBS4 ALDH1A2 FBN1 PRAMEF5 FBN2 KIF26B PRAMEF15 LRP1 LRP2 PRAMEF4 ALDH2 PRAMEF11 RYR2 PRAMEF6 DNAH11 | 2.88e-06 | 916 | 72 | 17 | MP:0000274 |
| MousePheno | cardiac hypertrophy | 7.19e-06 | 196 | 72 | 8 | MP:0001625 | |
| MousePheno | abnormal enzyme/coenzyme level | NPC1 FCRL2 ZMAT5 PRAMEF5 FBN2 TLR2 PRAMEF15 MTMR3 LRP1 G2E3 LTBP1 PRAMEF4 ALDH2 ALDH1A3 PDE10A ZDHHC13 MFSD1 SEPTIN6 PRAMEF11 PRAMEF6 NSD3 | 8.01e-06 | 1451 | 72 | 21 | MP:0005319 |
| MousePheno | abnormal skin morphology | CACNA1S FBLN1 FBN1 PRAMEF5 FBN2 STAG1 OR9G4 VCAN PRAMEF15 G2E3 PRAMEF4 ALDH9A1 ZDHHC13 MEAK7 ITGB4 PRAMEF27 ABCC6 ADGRL3 PRAMEF11 MOV10 PRAMEF6 | 8.36e-06 | 1455 | 72 | 21 | MP:0002060 |
| MousePheno | abnormal circulating enzyme level | FCRL2 ZMAT5 PRAMEF5 FBN2 TLR2 PRAMEF15 MTMR3 LRP1 G2E3 LTBP1 PRAMEF4 ALDH2 ALDH1A3 PDE10A ZDHHC13 MFSD1 SEPTIN6 PRAMEF11 PRAMEF6 NSD3 | 1.27e-05 | 1372 | 72 | 20 | MP:0001570 |
| MousePheno | abnormal pancreas morphology | CACNA1D PRAMEF5 OR9G4 TLR2 PRAMEF15 COL5A3 G2E3 PRAMEF4 PRAMEF11 PRAMEF6 | 1.73e-05 | 367 | 72 | 10 | MP:0001944 |
| MousePheno | micrognathia | 2.55e-05 | 68 | 72 | 5 | MP:0002639 | |
| MousePheno | long ribs | 2.62e-05 | 2 | 72 | 2 | MP:0004671 | |
| MousePheno | vascular ring | 3.00e-05 | 35 | 72 | 4 | MP:0010466 | |
| MousePheno | abnormal blood vessel morphology | NPC1 ADM CACNA1C CACNA1S FBLN1 THBS4 LIPA ALDH1A2 FBN1 STAG1 VCAN TLR2 LRP2 LTBP1 ZDHHC13 ITGB4 MFSD1 ABCC6 MOV10 DNAH11 | 3.56e-05 | 1472 | 72 | 20 | MP:0001614 |
| MousePheno | abnormal apoptosis | ADM CACNA1C CACNA1F FBLN1 PRAMEF5 FBN2 TLR2 PRAMEF15 LRP2 LAMB2 COL5A3 G2E3 PRAMEF4 ALDH2 ALDH1A3 ZDHHC13 PRAMEF27 PRAMEF11 PRAMEF6 | 3.76e-05 | 1353 | 72 | 19 | MP:0001648 |
| MousePheno | abnormal urinary bladder morphology | 3.83e-05 | 247 | 72 | 8 | MP:0000538 | |
| MousePheno | abnormal anterior eye segment morphology | NPC1 COL4A4 ZMAT5 PRAMEF5 FBN2 ZSCAN5DP SYNGR3 PRAMEF15 LRP1 PRAMEF4 ALDH2 ADAMTS14 ALDH1A3 ITGB4 PRAMEF27 PRAMEF11 PRAMEF6 | 3.91e-05 | 1117 | 72 | 17 | MP:0005193 |
| MousePheno | abnormal programmed cell death | ADM CACNA1C CACNA1F FBLN1 PRAMEF5 FBN2 TLR2 PRAMEF15 LRP2 LAMB2 COL5A3 G2E3 PRAMEF4 ALDH2 ALDH1A3 ZDHHC13 PRAMEF27 PRAMEF11 PRAMEF6 | 4.03e-05 | 1360 | 72 | 19 | MP:0014355 |
| MousePheno | increased apoptosis | ADM CACNA1F FBLN1 PRAMEF5 TLR2 PRAMEF15 LRP2 LAMB2 COL5A3 G2E3 PRAMEF4 ALDH2 ZDHHC13 PRAMEF27 PRAMEF11 PRAMEF6 | 4.18e-05 | 1008 | 72 | 16 | MP:0006042 |
| MousePheno | abnormal craniofacial morphology | NPC1 TTC8 CACNA1S FBLN1 ALDH1A2 COL11A2 FBN1 FBN2 STAG1 VCAN LRP1 LRP2 LTBP1 ALDH1A3 ITGB4 ABCC6 NSD3 SORL1 DNAH11 | 4.55e-05 | 1372 | 72 | 19 | MP:0000428 |
| MousePheno | craniofacial phenotype | NPC1 TTC8 CACNA1S FBLN1 ALDH1A2 COL11A2 FBN1 FBN2 STAG1 VCAN LRP1 LRP2 LTBP1 ALDH1A3 ITGB4 ABCC6 NSD3 SORL1 DNAH11 | 4.55e-05 | 1372 | 72 | 19 | MP:0005382 |
| MousePheno | increased cell death | ADM CACNA1F FBLN1 PRAMEF5 TLR2 PRAMEF15 LRP2 LAMB2 COL5A3 G2E3 PRAMEF4 ALDH2 ZDHHC13 PRAMEF27 PRAMEF11 PRAMEF6 | 4.77e-05 | 1019 | 72 | 16 | MP:0012556 |
| MousePheno | heart right ventricle hypertrophy | 6.24e-05 | 42 | 72 | 4 | MP:0000276 | |
| MousePheno | abnormal thoracic aorta morphology | 6.45e-05 | 134 | 72 | 6 | MP:0010468 | |
| MousePheno | abnormal vitreous body morphology | PRAMEF5 VCAN PRAMEF15 MYNN PRAMEF4 ALDH1A3 MFSD1 PRAMEF27 PRAMEF11 PRAMEF6 | 6.53e-05 | 429 | 72 | 10 | MP:0002699 |
| MousePheno | abnormal nose morphology | 7.65e-05 | 201 | 72 | 7 | MP:0002233 | |
| MousePheno | enlarged spleen | NPC1 LIPA FBN1 PRAMEF5 STAG1 OR9G4 VCAN PRAMEF15 PRAMEF4 ZDHHC13 MFSD1 PRAMEF11 RYR2 PRAMEF6 | 1.08e-04 | 862 | 72 | 14 | MP:0000691 |
| MousePheno | abnormal heart right ventricle wall morphology | 1.45e-04 | 52 | 72 | 4 | MP:0031534 | |
| MousePheno | abnormal heart right ventricle morphology | 1.49e-04 | 156 | 72 | 6 | MP:0003920 | |
| MousePheno | abnormal circulating amylase level | 1.49e-04 | 156 | 72 | 6 | MP:0008804 | |
| MousePheno | abnormal cecum morphology | 1.55e-04 | 99 | 72 | 5 | MP:0000494 | |
| MousePheno | abnormal heart ventricle size | 1.68e-04 | 228 | 72 | 7 | MP:0031543 | |
| MousePheno | limbs/digits/tail phenotype | CACNA1C CACNA1S ALDH1A2 FBN1 PRAMEF5 FBN2 VCAN SYNGR3 PRAMEF15 LRP1 LRP2 G2E3 LTBP1 PRAMEF4 PRAMEF11 PRAMEF6 DNAH11 | 1.71e-04 | 1258 | 72 | 17 | MP:0005371 |
| MousePheno | increased circulating enzyme level | FCRL2 ZMAT5 PRAMEF5 FBN2 PRAMEF15 MTMR3 LRP1 G2E3 PRAMEF4 ALDH1A3 ZDHHC13 MFSD1 SEPTIN6 PRAMEF11 PRAMEF6 NSD3 | 1.79e-04 | 1140 | 72 | 16 | MP:0014450 |
| MousePheno | abnormal heart ventricle morphology | ADM CACNA1C FBLN1 THBS4 ALDH1A2 FBN1 VCAN TLR2 LRP1 LRP2 LTBP1 RYR2 DNAH11 | 1.80e-04 | 793 | 72 | 13 | MP:0005294 |
| MousePheno | increased heart right ventricle size | 1.81e-04 | 55 | 72 | 4 | MP:0010563 | |
| MousePheno | increased enzyme/coenzyme level | FCRL2 ZMAT5 PRAMEF5 FBN2 PRAMEF15 MTMR3 LRP1 G2E3 PRAMEF4 ALDH1A3 ZDHHC13 MFSD1 SEPTIN6 PRAMEF11 PRAMEF6 NSD3 | 1.94e-04 | 1148 | 72 | 16 | MP:0014448 |
| MousePheno | abnormal lens morphology | COL4A4 PRAMEF5 ZSCAN5DP PRAMEF15 LRP1 PRAMEF4 ALDH2 ADAMTS14 ALDH1A3 PRAMEF27 PRAMEF11 PRAMEF6 | 2.16e-04 | 699 | 72 | 12 | MP:0001303 |
| MousePheno | abnormal circulating alanine transaminase level | PRAMEF5 TLR2 PRAMEF15 LTBP1 PRAMEF4 PDE10A ZDHHC13 MFSD1 PRAMEF11 PRAMEF6 | 2.22e-04 | 498 | 72 | 10 | MP:0001573 |
| MousePheno | abnormal heart left ventricle size | 2.31e-04 | 169 | 72 | 6 | MP:0010578 | |
| MousePheno | abnormal liver vasculature morphology | 2.33e-04 | 108 | 72 | 5 | MP:0009820 | |
| MousePheno | right aortic arch | 2.54e-04 | 60 | 72 | 4 | MP:0004158 | |
| MousePheno | azoospermia | 2.54e-04 | 244 | 72 | 7 | MP:0005159 | |
| MousePheno | abnormal liver perisinusoidal space morphology | 2.59e-04 | 5 | 72 | 2 | MP:0008988 | |
| MousePheno | abnormal kidney size | COL4A4 CACNA1C ALDH1A2 PRAMEF5 STAG1 KIF26B OR9G4 PRAMEF15 G2E3 PRAMEF4 PRAMEF11 PRAMEF6 | 2.62e-04 | 714 | 72 | 12 | MP:0002706 |
| MousePheno | increased circulating protein level | FCRL2 ZMAT5 COL11A2 PRAMEF5 FBN2 OR9G4 PRAMEF15 MTMR3 LRP1 G2E3 PRAMEF4 ALDH1A3 ZDHHC13 MFSD1 SEPTIN6 PRAMEF11 PRAMEF6 NSD3 | 2.64e-04 | 1433 | 72 | 18 | MP:0014501 |
| MousePheno | abnormal thoracic cavity morphology | 2.78e-04 | 25 | 72 | 3 | MP:0004733 | |
| MousePheno | increased heart ventricle size | 2.79e-04 | 175 | 72 | 6 | MP:0008772 | |
| MousePheno | abnormal stomach morphology | 2.81e-04 | 248 | 72 | 7 | MP:0000470 | |
| MousePheno | abnormal nephron morphology | 3.24e-04 | 426 | 72 | 9 | MP:0003881 | |
| MousePheno | enlarged urinary bladder | 3.24e-04 | 116 | 72 | 5 | MP:0011874 | |
| MousePheno | abnormal spleen size | NPC1 LIPA FBN1 PRAMEF5 STAG1 OR9G4 VCAN PRAMEF15 PRAMEF4 ZDHHC13 MFSD1 PRAMEF11 RYR2 PRAMEF6 NSD3 DNAH11 | 3.31e-04 | 1203 | 72 | 16 | MP:0002224 |
| MousePheno | absent gametes | 3.40e-04 | 256 | 72 | 7 | MP:0001117 | |
| MousePheno | increased circulating amylase level | 3.65e-04 | 119 | 72 | 5 | MP:0008806 | |
| MousePheno | abnormal aortic arch morphology | 3.65e-04 | 119 | 72 | 5 | MP:0004113 | |
| MousePheno | abnormal small intestine morphology | 3.97e-04 | 187 | 72 | 6 | MP:0000496 | |
| MousePheno | increased male germ cell apoptosis | 4.20e-04 | 189 | 72 | 6 | MP:0014052 | |
| MousePheno | abnormal muscle electrophysiology | 5.84e-04 | 32 | 72 | 3 | MP:0004145 | |
| MousePheno | abnormal heart left ventricle morphology | 5.99e-04 | 369 | 72 | 8 | MP:0003921 | |
| MousePheno | increased heart left ventricle size | 6.28e-04 | 134 | 72 | 5 | MP:0010579 | |
| MousePheno | abnormal cardiac outflow tract development | 6.28e-04 | 134 | 72 | 5 | MP:0006126 | |
| MousePheno | hearing/vestibular/ear phenotype | COL4A4 CACNA1D FBLN1 CLDN11 ALDH1A2 COL11A2 PRAMEF5 FBN2 PRAMEF15 LRP2 PRAMEF4 PRAMEF11 PRAMEF6 | 6.44e-04 | 905 | 72 | 13 | MP:0005377 |
| MousePheno | visceromegaly | NPC1 LIPA FBN1 PRAMEF5 STAG1 OR9G4 VCAN PRAMEF15 PRAMEF4 ZDHHC13 MFSD1 PRAMEF11 RYR2 PRAMEF6 | 6.73e-04 | 1030 | 72 | 14 | MP:0013328 |
| MousePheno | abnormal facial morphology | NPC1 TTC8 CACNA1S FBLN1 COL11A2 STAG1 LRP2 LTBP1 ALDH1A3 ITGB4 ABCC6 NSD3 SORL1 | 6.78e-04 | 910 | 72 | 13 | MP:0003743 |
| MousePheno | abnormal heart right ventricle size | 6.92e-04 | 78 | 72 | 4 | MP:0010577 | |
| MousePheno | abnormal auditory brainstem response | COL4A4 CACNA1D CLDN11 COL11A2 PRAMEF5 PRAMEF15 LRP2 PRAMEF4 PRAMEF11 PRAMEF6 | 6.99e-04 | 576 | 72 | 10 | MP:0004738 |
| MousePheno | abnormal liver sinusoid morphology | 7.26e-04 | 79 | 72 | 4 | MP:0008989 | |
| MousePheno | abnormal heart septum morphology | 8.32e-04 | 388 | 72 | 8 | MP:0006113 | |
| MousePheno | abnormal brown adipose tissue amount | 8.36e-04 | 82 | 72 | 4 | MP:0001778 | |
| MousePheno | abnormal viscerocranium morphology | CACNA1S FBLN1 COL11A2 FBN1 FBN2 STAG1 LRP2 LTBP1 ALDH1A3 DNAH11 | 8.75e-04 | 593 | 72 | 10 | MP:0005274 |
| MousePheno | abnormal hearing electrophysiology | COL4A4 CACNA1D CLDN11 COL11A2 PRAMEF5 PRAMEF15 LRP2 PRAMEF4 PRAMEF11 PRAMEF6 | 8.86e-04 | 594 | 72 | 10 | MP:0006335 |
| MousePheno | increased kidney weight | 8.97e-04 | 145 | 72 | 5 | MP:0003917 | |
| MousePheno | overexpanded pulmonary alveolus | 8.98e-04 | 37 | 72 | 3 | MP:0001183 | |
| MousePheno | sensorineural hearing loss | 8.98e-04 | 37 | 72 | 3 | MP:0004740 | |
| MousePheno | emphysema | 8.98e-04 | 37 | 72 | 3 | MP:0001958 | |
| MousePheno | abnormal aortic arch and aortic arch branch attachment | 8.98e-04 | 37 | 72 | 3 | MP:0010464 | |
| MousePheno | abnormal truncus arteriosus septation | 9.15e-04 | 84 | 72 | 4 | MP:0010454 | |
| MousePheno | abnormal systemic artery morphology | 9.44e-04 | 304 | 72 | 7 | MP:0011655 | |
| MousePheno | sensorineural hearing impairment | 9.71e-04 | 38 | 72 | 3 | MP:0006329 | |
| MousePheno | cataract | COL4A4 PRAMEF5 ZSCAN5DP PRAMEF15 PRAMEF4 ADAMTS14 PRAMEF27 PRAMEF11 PRAMEF6 | 9.81e-04 | 497 | 72 | 9 | MP:0001304 |
| MousePheno | abnormal chest morphology | 1.05e-03 | 39 | 72 | 3 | MP:0004134 | |
| MousePheno | abnormal aorta morphology | 1.05e-03 | 225 | 72 | 6 | MP:0000272 | |
| MousePheno | abnormal tail morphology | 1.06e-03 | 403 | 72 | 8 | MP:0002111 | |
| MousePheno | cyanosis | 1.07e-03 | 226 | 72 | 6 | MP:0001575 | |
| MousePheno | atrial fibrillation | 1.15e-03 | 10 | 72 | 2 | MP:0008543 | |
| MousePheno | abnormal liver lobule morphology | 1.15e-03 | 229 | 72 | 6 | MP:0008987 | |
| MousePheno | decreased exploration in new environment | NPC1 CACNA1C PRAMEF5 PRAMEF15 PRAMEF4 PDE10A PRAMEF11 PRAMEF6 NSD3 | 1.18e-03 | 510 | 72 | 9 | MP:0001417 |
| MousePheno | abnormal seminal vesicle morphology | 1.25e-03 | 319 | 72 | 7 | MP:0002059 | |
| MousePheno | abnormal male germ cell apoptosis | 1.34e-03 | 236 | 72 | 6 | MP:0008280 | |
| MousePheno | abnormal muscle morphology | ADM CACNA1C CACNA1S FBLN1 ALDH1A2 FBN1 FBN2 STAG1 LRP1 LRP2 LTBP1 ZDHHC13 RYR2 DNAH11 | 1.35e-03 | 1106 | 72 | 14 | MP:0002108 |
| MousePheno | abnormal kidney cortex morphology | 1.37e-03 | 324 | 72 | 7 | MP:0000521 | |
| MousePheno | calcified artery | 1.40e-03 | 11 | 72 | 2 | MP:0006133 | |
| MousePheno | fusion of glossopharyngeal and vagus nerve | 1.40e-03 | 11 | 72 | 2 | MP:0004568 | |
| MousePheno | decreased brown adipose tissue amount | 1.49e-03 | 44 | 72 | 3 | MP:0001780 | |
| MousePheno | abnormal liver parenchyma morphology | 1.56e-03 | 243 | 72 | 6 | MP:0008986 | |
| MousePheno | abnormal male germ cell physiology | 1.59e-03 | 244 | 72 | 6 | MP:0020362 | |
| MousePheno | abnormal hearing physiology | COL4A4 CACNA1D CLDN11 COL11A2 PRAMEF5 PRAMEF15 LRP2 PRAMEF4 PRAMEF11 PRAMEF6 | 1.61e-03 | 643 | 72 | 10 | MP:0001963 |
| MousePheno | abnormal hepatocyte morphology | 1.64e-03 | 166 | 72 | 5 | MP:0000607 | |
| Domain | EGF_Ca-bd_CS | 1.39e-12 | 97 | 91 | 11 | IPR018097 | |
| Domain | EGF_CA | 1.75e-12 | 99 | 91 | 11 | PS01187 | |
| Domain | EGF-like_CS | FBLN1 THBS4 FBN1 FBN2 VCAN LRP1 LRP2 DLK2 LAMB2 LAMC3 LTBP1 ITGB4 FBN3 LRP8 SORL1 | 2.15e-12 | 261 | 91 | 15 | IPR013032 |
| Domain | EGF_2 | FBLN1 THBS4 FBN1 FBN2 VCAN LRP1 LRP2 DLK2 LAMB2 LAMC3 LTBP1 ITGB4 FBN3 LRP8 SORL1 | 2.68e-12 | 265 | 91 | 15 | PS01186 |
| Domain | EGF | FBLN1 THBS4 FBN1 FBN2 VCAN LRP1 LRP2 DLK2 LAMB2 LAMC3 LTBP1 FBN3 LRP8 SORL1 | 7.66e-12 | 235 | 91 | 14 | SM00181 |
| Domain | EGF-like_dom | FBLN1 THBS4 FBN1 FBN2 VCAN LRP1 LRP2 DLK2 LAMB2 LAMC3 LTBP1 FBN3 LRP8 SORL1 | 1.67e-11 | 249 | 91 | 14 | IPR000742 |
| Domain | EGF_CA | 1.78e-11 | 122 | 91 | 11 | SM00179 | |
| Domain | EGF-like_Ca-bd_dom | 2.13e-11 | 124 | 91 | 11 | IPR001881 | |
| Domain | EGF_1 | FBLN1 THBS4 FBN1 FBN2 VCAN LRP1 LRP2 DLK2 LAMB2 LAMC3 LTBP1 ITGB4 FBN3 LRP8 | 2.30e-11 | 255 | 91 | 14 | PS00022 |
| Domain | cEGF | 3.14e-11 | 26 | 91 | 7 | IPR026823 | |
| Domain | cEGF | 3.14e-11 | 26 | 91 | 7 | PF12662 | |
| Domain | ASX_HYDROXYL | 5.49e-11 | 100 | 91 | 10 | PS00010 | |
| Domain | EGF-type_Asp/Asn_hydroxyl_site | 9.86e-11 | 106 | 91 | 10 | IPR000152 | |
| Domain | Growth_fac_rcpt_ | 2.58e-10 | 156 | 91 | 11 | IPR009030 | |
| Domain | PRAME_family | 2.92e-10 | 19 | 91 | 6 | IPR026271 | |
| Domain | EGF_CA | 3.49e-10 | 86 | 91 | 9 | PF07645 | |
| Domain | VDCC_L_a1su | 5.27e-10 | 4 | 91 | 4 | IPR005446 | |
| Domain | EGF_3 | FBLN1 THBS4 FBN1 FBN2 VCAN LRP1 LRP2 DLK2 LTBP1 FBN3 LRP8 SORL1 | 1.56e-09 | 235 | 91 | 12 | PS50026 |
| Domain | VDCC_a1su_IQ | 1.83e-08 | 7 | 91 | 4 | IPR014873 | |
| Domain | GPHH | 1.83e-08 | 7 | 91 | 4 | PF16905 | |
| Domain | TB | 1.83e-08 | 7 | 91 | 4 | PF00683 | |
| Domain | GPHH_dom | 1.83e-08 | 7 | 91 | 4 | IPR031649 | |
| Domain | Ca_chan_IQ | 1.83e-08 | 7 | 91 | 4 | SM01062 | |
| Domain | Ca_chan_IQ | 1.83e-08 | 7 | 91 | 4 | PF08763 | |
| Domain | - | 3.64e-08 | 8 | 91 | 4 | 3.90.290.10 | |
| Domain | TB | 6.52e-08 | 9 | 91 | 4 | PS51364 | |
| Domain | TB_dom | 6.52e-08 | 9 | 91 | 4 | IPR017878 | |
| Domain | VDCCAlpha1 | 1.08e-07 | 10 | 91 | 4 | IPR002077 | |
| Domain | CAC1F_C | 1.12e-07 | 3 | 91 | 3 | IPR031688 | |
| Domain | CAC1F_C | 1.12e-07 | 3 | 91 | 3 | PF16885 | |
| Domain | FBN | 1.12e-07 | 3 | 91 | 3 | IPR011398 | |
| Domain | EGF | 1.82e-07 | 126 | 91 | 8 | PF00008 | |
| Domain | Ldl_recept_b | 5.09e-07 | 14 | 91 | 4 | PF00058 | |
| Domain | LDLRB | 5.09e-07 | 14 | 91 | 4 | PS51120 | |
| Domain | LY | 6.91e-07 | 15 | 91 | 4 | SM00135 | |
| Domain | LDLR_classB_rpt | 6.91e-07 | 15 | 91 | 4 | IPR000033 | |
| Domain | Ald_DH_CS_GLU | 9.18e-07 | 16 | 91 | 4 | IPR029510 | |
| Domain | Ald_DH_CS_CYS | 1.20e-06 | 17 | 91 | 4 | IPR016160 | |
| Domain | ALDEHYDE_DEHYDR_GLU | 1.53e-06 | 18 | 91 | 4 | PS00687 | |
| Domain | ALDEHYDE_DEHYDR_CYS | 1.53e-06 | 18 | 91 | 4 | PS00070 | |
| Domain | Ald_DH_C | 1.93e-06 | 19 | 91 | 4 | IPR016163 | |
| Domain | Ald_DH_N | 1.93e-06 | 19 | 91 | 4 | IPR016162 | |
| Domain | Ald_DH/histidinol_DH | 1.93e-06 | 19 | 91 | 4 | IPR016161 | |
| Domain | - | 1.93e-06 | 19 | 91 | 4 | 3.40.605.10 | |
| Domain | Aldedh | 1.93e-06 | 19 | 91 | 4 | PF00171 | |
| Domain | Aldehyde_DH_dom | 1.93e-06 | 19 | 91 | 4 | IPR015590 | |
| Domain | - | 1.93e-06 | 19 | 91 | 4 | 3.40.309.10 | |
| Domain | Ion_trans_dom | 1.98e-05 | 114 | 91 | 6 | IPR005821 | |
| Domain | Ion_trans | 1.98e-05 | 114 | 91 | 6 | PF00520 | |
| Domain | - | 3.81e-05 | 39 | 91 | 4 | 2.120.10.30 | |
| Domain | LDLR_class-A_CS | 4.21e-05 | 40 | 91 | 4 | IPR023415 | |
| Domain | Ldl_recept_a | 6.74e-05 | 45 | 91 | 4 | PF00057 | |
| Domain | - | 7.36e-05 | 46 | 91 | 4 | 4.10.400.10 | |
| Domain | 6-blade_b-propeller_TolB-like | 7.36e-05 | 46 | 91 | 4 | IPR011042 | |
| Domain | LDLRA_1 | 8.71e-05 | 48 | 91 | 4 | PS01209 | |
| Domain | LDLRA_2 | 9.45e-05 | 49 | 91 | 4 | PS50068 | |
| Domain | LDrepeatLR_classA_rpt | 9.45e-05 | 49 | 91 | 4 | IPR002172 | |
| Domain | LDLa | 9.45e-05 | 49 | 91 | 4 | SM00192 | |
| Domain | Olfact_rcpt | 1.26e-04 | 393 | 91 | 9 | IPR000725 | |
| Domain | STAG | 1.40e-04 | 4 | 91 | 2 | IPR013721 | |
| Domain | STAG | 1.40e-04 | 4 | 91 | 2 | PF08514 | |
| Domain | Channel_four-helix_dom | 1.71e-04 | 57 | 91 | 4 | IPR027359 | |
| Domain | - | 1.71e-04 | 57 | 91 | 4 | 1.20.120.350 | |
| Domain | - | LRR1 PRAMEF25 PRAMEF5 TLR2 PRAMEF15 PRAMEF4 PRAMEF27 PRAMEF6 | 1.72e-04 | 321 | 91 | 8 | 3.80.10.10 |
| Domain | TSPN | 1.85e-04 | 23 | 91 | 3 | SM00210 | |
| Domain | L_dom-like | LRR1 PRAMEF25 PRAMEF5 TLR2 PRAMEF15 PRAMEF4 PRAMEF27 PRAMEF6 | 1.99e-04 | 328 | 91 | 8 | IPR032675 |
| Domain | hEGF | 3.36e-04 | 28 | 91 | 3 | PF12661 | |
| Domain | Fib_collagen_C | 1.25e-03 | 11 | 91 | 2 | IPR000885 | |
| Domain | COLFI | 1.25e-03 | 11 | 91 | 2 | PF01410 | |
| Domain | NC1_FIB | 1.25e-03 | 11 | 91 | 2 | PS51461 | |
| Domain | Fib_collagen_C | 1.25e-03 | 11 | 91 | 2 | PD002078 | |
| Domain | COLFI | 1.25e-03 | 11 | 91 | 2 | SM00038 | |
| Domain | Septin | 1.77e-03 | 13 | 91 | 2 | PF00735 | |
| Domain | G_SEPTIN_dom | 1.77e-03 | 13 | 91 | 2 | IPR030379 | |
| Domain | G_SEPTIN | 1.77e-03 | 13 | 91 | 2 | PS51719 | |
| Domain | Myotubularin-like_Pase_dom | 2.06e-03 | 14 | 91 | 2 | IPR010569 | |
| Domain | TIL_dom | 2.06e-03 | 14 | 91 | 2 | IPR002919 | |
| Domain | PPASE_MYOTUBULARIN | 2.06e-03 | 14 | 91 | 2 | PS51339 | |
| Domain | Myotubularin_fam | 2.06e-03 | 14 | 91 | 2 | IPR030564 | |
| Domain | Myotub-related | 2.06e-03 | 14 | 91 | 2 | PF06602 | |
| Domain | Septin | 2.06e-03 | 14 | 91 | 2 | IPR016491 | |
| Domain | Laminin_N | 2.70e-03 | 16 | 91 | 2 | IPR008211 | |
| Domain | LAMININ_NTER | 2.70e-03 | 16 | 91 | 2 | PS51117 | |
| Domain | Laminin_N | 2.70e-03 | 16 | 91 | 2 | PF00055 | |
| Domain | LamNT | 2.70e-03 | 16 | 91 | 2 | SM00136 | |
| Domain | Laminin_G | 2.84e-03 | 58 | 91 | 3 | IPR001791 | |
| Domain | EGF_extracell | 3.13e-03 | 60 | 91 | 3 | IPR013111 | |
| Domain | EGF_2 | 3.13e-03 | 60 | 91 | 3 | PF07974 | |
| Domain | ConA-like_dom | 4.35e-03 | 219 | 91 | 5 | IPR013320 | |
| Pathway | REACTOME_EXTRACELLULAR_MATRIX_ORGANIZATION | COL4A4 FBLN1 COL11A2 FBN1 FBN2 VCAN LAMB2 COL5A3 LAMC3 LTBP1 ADAMTS14 ITGB4 FBN3 | 1.28e-09 | 300 | 67 | 13 | M610 |
| Pathway | KEGG_MEDICUS_VARIANT_SCRAPIE_CONFORMATION_PRPSC_TO_VGCC_CA2_APOPTOTIC_PATHWAY | 6.94e-09 | 6 | 67 | 4 | M47762 | |
| Pathway | KEGG_ECM_RECEPTOR_INTERACTION | 1.35e-07 | 84 | 67 | 7 | M7098 | |
| Pathway | REACTOME_NON_INTEGRIN_MEMBRANE_ECM_INTERACTIONS | 3.39e-07 | 59 | 67 | 6 | M27218 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_ABETA_TO_VGCC_CA2_APOPTOTIC_PATHWAY_N01004 | 4.50e-07 | 14 | 67 | 4 | M47692 | |
| Pathway | REACTOME_MOLECULES_ASSOCIATED_WITH_ELASTIC_FIBRES | 8.07e-07 | 37 | 67 | 5 | M27134 | |
| Pathway | WP_ARRHYTHMOGENIC_RIGHT_VENTRICULAR_CARDIOMYOPATHY | 1.32e-06 | 74 | 67 | 6 | M39462 | |
| Pathway | KEGG_ARRHYTHMOGENIC_RIGHT_VENTRICULAR_CARDIOMYOPATHY_ARVC | 1.32e-06 | 74 | 67 | 6 | M16376 | |
| Pathway | REACTOME_NCAM1_INTERACTIONS | 1.55e-06 | 42 | 67 | 5 | M7169 | |
| Pathway | REACTOME_ELASTIC_FIBRE_FORMATION | 1.96e-06 | 44 | 67 | 5 | M26969 | |
| Pathway | KEGG_HYPERTROPHIC_CARDIOMYOPATHY_HCM | 2.60e-06 | 83 | 67 | 6 | M8728 | |
| Pathway | REACTOME_EXTRACELLULAR_MATRIX_ORGANIZATION | 3.39e-06 | 258 | 67 | 9 | MM14572 | |
| Pathway | KEGG_MEDICUS_REFERENCE_VGCC_CA2_APOPTOTIC_PATHWAY | 3.86e-06 | 23 | 67 | 4 | M47666 | |
| Pathway | KEGG_DILATED_CARDIOMYOPATHY | 4.18e-06 | 90 | 67 | 6 | M835 | |
| Pathway | WP_HYPOTHESIZED_PATHWAYS_IN_PATHOGENESIS_OF_CARDIOVASCULAR_DISEASE | 5.47e-06 | 25 | 67 | 4 | M39713 | |
| Pathway | KEGG_MEDICUS_REFERENCE_CA2_ENTRY_VOLTAGE_GATED_CA2_CHANNEL | 5.47e-06 | 25 | 67 | 4 | M47948 | |
| Pathway | REACTOME_SENSORY_PERCEPTION | OR5W2 OR2B11 CACNA1D OR9G1 OR7C2 OR7C1 OR9G4 OR9Q2 LRP1 LRP2 OR10T2 OR9G9 LRP8 | 7.59e-06 | 636 | 67 | 13 | M41834 |
| Pathway | REACTOME_MET_ACTIVATES_PTK2_SIGNALING | 1.16e-05 | 30 | 67 | 4 | M27772 | |
| Pathway | REACTOME_LAMININ_INTERACTIONS | 1.16e-05 | 30 | 67 | 4 | M27216 | |
| Pathway | REACTOME_NCAM_SIGNALING_FOR_NEURITE_OUT_GROWTH | 1.18e-05 | 63 | 67 | 5 | M11187 | |
| Pathway | REACTOME_NON_INTEGRIN_MEMBRANE_ECM_INTERACTIONS | 1.52e-05 | 32 | 67 | 4 | MM14924 | |
| Pathway | KEGG_MEDICUS_REFERENCE_CA2_CAM_VGCC_RYR_SIGNALING_PATHWAY | 1.65e-05 | 11 | 67 | 3 | M47958 | |
| Pathway | WP_ALZHEIMERS_DISEASE | 2.61e-05 | 74 | 67 | 5 | MM15962 | |
| Pathway | WP_FOCAL_ADHESION | 2.87e-05 | 187 | 67 | 7 | MM15913 | |
| Pathway | KEGG_CARDIAC_MUSCLE_CONTRACTION | 3.58e-05 | 79 | 67 | 5 | M17673 | |
| Pathway | REACTOME_MET_PROMOTES_CELL_MOTILITY | 4.13e-05 | 41 | 67 | 4 | M27778 | |
| Pathway | KEGG_FOCAL_ADHESION | 4.27e-05 | 199 | 67 | 7 | M7253 | |
| Pathway | REACTOME_DEGRADATION_OF_THE_EXTRACELLULAR_MATRIX | 5.23e-05 | 140 | 67 | 6 | M587 | |
| Pathway | REACTOME_COLLAGEN_FORMATION | 6.70e-05 | 90 | 67 | 5 | M631 | |
| Pathway | REACTOME_OLFACTORY_SIGNALING_PATHWAY | 1.49e-04 | 417 | 67 | 9 | M4072 | |
| Pathway | REACTOME_ASSEMBLY_OF_COLLAGEN_FIBRILS_AND_OTHER_MULTIMERIC_STRUCTURES | 1.98e-04 | 61 | 67 | 4 | M27103 | |
| Pathway | REACTOME_COLLAGEN_BIOSYNTHESIS_AND_MODIFYING_ENZYMES | 1.98e-04 | 61 | 67 | 4 | MM14637 | |
| Pathway | REACTOME_DEGRADATION_OF_THE_EXTRACELLULAR_MATRIX | 2.05e-04 | 114 | 67 | 5 | MM14571 | |
| Pathway | PID_INTEGRIN1_PATHWAY | 2.69e-04 | 66 | 67 | 4 | M18 | |
| Pathway | REACTOME_COLLAGEN_BIOSYNTHESIS_AND_MODIFYING_ENZYMES | 2.85e-04 | 67 | 67 | 4 | M26999 | |
| Pathway | WP_FLUOROACETIC_ACID_TOXICITY | 3.30e-04 | 6 | 67 | 2 | M40063 | |
| Pathway | KEGG_HISTIDINE_METABOLISM | 3.43e-04 | 29 | 67 | 3 | M12524 | |
| Pathway | WP_FOCAL_ADHESION | 3.58e-04 | 199 | 67 | 6 | M39402 | |
| Pathway | WP_ETHANOL_EFFECTS_ON_HISTONE_MODIFICATIONS | 4.19e-04 | 31 | 67 | 3 | M39714 | |
| Pathway | REACTOME_MOLECULES_ASSOCIATED_WITH_ELASTIC_FIBRES | 4.61e-04 | 32 | 67 | 3 | MM14854 | |
| Pathway | REACTOME_ECM_PROTEOGLYCANS | 4.62e-04 | 76 | 67 | 4 | M27219 | |
| Pathway | REACTOME_COLLAGEN_FORMATION | 4.62e-04 | 76 | 67 | 4 | MM14573 | |
| Pathway | REACTOME_SIGNALING_BY_MET | 5.36e-04 | 79 | 67 | 4 | M27643 | |
| Pathway | WP_FOCAL_ADHESION_PI3KAKTMTORSIGNALING | 5.59e-04 | 302 | 67 | 7 | M39719 | |
| Pathway | KEGG_MEDICUS_REFERENCE_PLASMIN_MEDIATED_ACTIVATION_OF_LATENT_TGF_BETA | 6.12e-04 | 8 | 67 | 2 | M47850 | |
| Pathway | REACTOME_ELASTIC_FIBRE_FORMATION | 8.30e-04 | 39 | 67 | 3 | MM14601 | |
| Pathway | WP_FOCAL_ADHESION_PI3KAKTMTOR_SIGNALING_PATHWAY | 8.78e-04 | 326 | 67 | 7 | MM15917 | |
| Pathway | REACTOME_COLLAGEN_CHAIN_TRIMERIZATION | 9.61e-04 | 41 | 67 | 3 | MM15538 | |
| Pathway | KEGG_LIMONENE_AND_PINENE_DEGRADATION | 9.77e-04 | 10 | 67 | 2 | M17395 | |
| Pathway | KEGG_ALZHEIMERS_DISEASE | 1.14e-03 | 166 | 67 | 5 | M16024 | |
| Pathway | KEGG_LYSINE_DEGRADATION | 1.18e-03 | 44 | 67 | 3 | M13720 | |
| Pathway | REACTOME_COLLAGEN_CHAIN_TRIMERIZATION | 1.18e-03 | 44 | 67 | 3 | M27812 | |
| Pathway | PID_INTEGRIN4_PATHWAY | 1.19e-03 | 11 | 67 | 2 | M158 | |
| Pathway | WP_NEPHROTIC_SYNDROME | 1.26e-03 | 45 | 67 | 3 | M39864 | |
| Pathway | REACTOME_METABOLISM_OF_FAT_SOLUBLE_VITAMINS | 1.26e-03 | 45 | 67 | 3 | MM15344 | |
| Pathway | PID_A6B1_A6B4_INTEGRIN_PATHWAY | 1.35e-03 | 46 | 67 | 3 | M239 | |
| Pathway | KEGG_GNRH_SIGNALING_PATHWAY | 1.35e-03 | 101 | 67 | 4 | M1979 | |
| Pathway | REACTOME_METABOLISM_OF_FAT_SOLUBLE_VITAMINS | 1.52e-03 | 48 | 67 | 3 | M27642 | |
| Pathway | WP_TRYPTOPHAN_METABOLISM | 1.52e-03 | 48 | 67 | 3 | MM15902 | |
| Pathway | KEGG_CALCIUM_SIGNALING_PATHWAY | 1.56e-03 | 178 | 67 | 5 | M2890 | |
| Pathway | REACTOME_ASSEMBLY_OF_COLLAGEN_FIBRILS_AND_OTHER_MULTIMERIC_STRUCTURES | 1.71e-03 | 50 | 67 | 3 | MM14796 | |
| Pathway | REACTOME_COLLAGEN_DEGRADATION | 2.03e-03 | 53 | 67 | 3 | MM14566 | |
| Pathway | REACTOME_SENSORY_PERCEPTION | 2.07e-03 | 190 | 67 | 5 | MM15687 | |
| Pathway | WP_FATTY_ACIDS_AND_LIPOPROTEINS_TRANSPORT_IN_HEPATOCYTES | 2.15e-03 | 381 | 67 | 7 | M48063 | |
| Pathway | KEGG_VASCULAR_SMOOTH_MUSCLE_CONTRACTION | 2.17e-03 | 115 | 67 | 4 | M9387 | |
| Pathway | REACTOME_LAMININ_INTERACTIONS | 2.25e-03 | 15 | 67 | 2 | MM14922 | |
| Pathway | KEGG_OLFACTORY_TRANSDUCTION | 2.42e-03 | 389 | 67 | 7 | M14091 | |
| Pathway | REACTOME_SIGNALING_BY_PDGF | 2.50e-03 | 57 | 67 | 3 | MM14713 | |
| Pathway | REACTOME_SIGNALING_BY_PDGF | 2.63e-03 | 58 | 67 | 3 | M2049 | |
| Pathway | REACTOME_REGULATION_OF_INSULIN_LIKE_GROWTH_FACTOR_IGF_TRANSPORT_AND_UPTAKE_BY_INSULIN_LIKE_GROWTH_FACTOR_BINDING_PROTEINS_IGFBPS | 2.85e-03 | 124 | 67 | 4 | M27285 | |
| Pathway | WP_DEGRADATION_PATHWAY_OF_SPHINGOLIPIDS_INCLUDING_DISEASES | 2.89e-03 | 17 | 67 | 2 | M39638 | |
| Pathway | KEGG_GLYCOLYSIS_GLUCONEOGENESIS | 3.18e-03 | 62 | 67 | 3 | M11521 | |
| Pathway | REACTOME_LDL_CLEARANCE | 3.24e-03 | 18 | 67 | 2 | MM15565 | |
| Pathway | REACTOME_COLLAGEN_DEGRADATION | 3.48e-03 | 64 | 67 | 3 | M26953 | |
| Pathway | REACTOME_LDL_CLEARANCE | 3.61e-03 | 19 | 67 | 2 | M27846 | |
| Pathway | REACTOME_MET_ACTIVATES_PTK2_SIGNALING | 3.61e-03 | 19 | 67 | 2 | MM15512 | |
| Pathway | REACTOME_NCAM1_INTERACTIONS | 4.00e-03 | 20 | 67 | 2 | MM15061 | |
| Pathway | KEGG_MEDICUS_REFERENCE_CARDIAC_TYPE_VGCC_RYR_SIGNALING | 4.41e-03 | 21 | 67 | 2 | M47950 | |
| Pathway | REACTOME_RA_BIOSYNTHESIS_PATHWAY | 4.83e-03 | 22 | 67 | 2 | M27445 | |
| Pathway | KEGG_BETA_ALANINE_METABOLISM | 4.83e-03 | 22 | 67 | 2 | M2668 | |
| Pathway | WP_PRIMARY_FOCAL_SEGMENTAL_GLOMERULOSCLEROSIS_FSGS | 4.84e-03 | 72 | 67 | 3 | M39403 | |
| Pathway | WP_CHOLESTEROL_METABOLISM | 4.84e-03 | 72 | 67 | 3 | M46457 | |
| Pathway | WP_PRIMARY_FOCAL_SEGMENTAL_GLOMERULOSCLEROSIS_FSGS | 5.03e-03 | 73 | 67 | 3 | MM15906 | |
| Pathway | WP_CALCIUM_REGULATION_IN_CARDIAC_CELLS | 5.23e-03 | 147 | 67 | 4 | MM15854 | |
| Pathway | WP_PI3KAKT_SIGNALING | 5.39e-03 | 339 | 67 | 6 | M39736 | |
| Pathway | REACTOME_INTEGRIN_CELL_SURFACE_INTERACTIONS | 5.63e-03 | 76 | 67 | 3 | MM14867 | |
| Pathway | PID_TOLL_ENDOGENOUS_PATHWAY | 5.74e-03 | 24 | 67 | 2 | M264 | |
| Pathway | WP_CALCIUM_REGULATION_IN_CARDIAC_CELLS | 5.75e-03 | 151 | 67 | 4 | M39329 | |
| Pathway | KEGG_ASCORBATE_AND_ALDARATE_METABOLISM | 6.22e-03 | 25 | 67 | 2 | M605 | |
| Pubmed | 1.25e-11 | 20 | 94 | 6 | 26694250 | ||
| Pubmed | 2.39e-11 | 22 | 94 | 6 | 31729367 | ||
| Pubmed | 5.00e-11 | 4 | 94 | 4 | 20937870 | ||
| Pubmed | 5.63e-11 | 25 | 94 | 6 | 37451217 | ||
| Pubmed | 1.19e-10 | 28 | 94 | 6 | 25089626 | ||
| Pubmed | 5.05e-10 | 35 | 94 | 6 | 19389355 | ||
| Pubmed | Differential expression of PRAMEL1, a cancer/testis antigen, during spermatogenesis in the mouse. | 7.81e-10 | 17 | 94 | 5 | 23565261 | |
| Pubmed | 7.81e-10 | 17 | 94 | 5 | 37781892 | ||
| Pubmed | 1.08e-09 | 18 | 94 | 5 | 23894331 | ||
| Pubmed | Pramel15 facilitates zygotic nuclear DNMT1 degradation and DNA demethylation. | 1.08e-09 | 18 | 94 | 5 | 39181896 | |
| Pubmed | Oogenesin is a novel mouse protein expressed in oocytes and early cleavage-stage embryos. | 1.08e-09 | 18 | 94 | 5 | 12890732 | |
| Pubmed | Oocyte-specific gene Oog1 suppresses the expression of spermatogenesis-specific genes in oocytes. | 1.08e-09 | 18 | 94 | 5 | 29731491 | |
| Pubmed | 1.08e-09 | 18 | 94 | 5 | 14675769 | ||
| Pubmed | Pramel7 mediates ground-state pluripotency through proteasomal-epigenetic combined pathways. | 1.46e-09 | 19 | 94 | 5 | 28604677 | |
| Pubmed | 1.74e-09 | 7 | 94 | 4 | 12900400 | ||
| Pubmed | 1.94e-09 | 20 | 94 | 5 | 16580637 | ||
| Pubmed | Pramel7 mediates LIF/STAT3-dependent self-renewal in embryonic stem cells. | 1.94e-09 | 20 | 94 | 5 | 21425410 | |
| Pubmed | Characterization of the Extracellular Matrix of Normal and Diseased Tissues Using Proteomics. | 3.51e-09 | 135 | 94 | 8 | 28675934 | |
| Pubmed | 4.19e-09 | 23 | 94 | 5 | 19480014 | ||
| Pubmed | Incomplete reactivation of Oct4-related genes in mouse embryos cloned from somatic nuclei. | 6.59e-09 | 25 | 94 | 5 | 12620990 | |
| Pubmed | Expression profiling in transgenic FVB/N embryonic stem cells overexpressing STAT3. | 8.14e-09 | 26 | 94 | 5 | 18500982 | |
| Pubmed | 1.20e-08 | 58 | 94 | 6 | 31598710 | ||
| Pubmed | Thirteen Ovary-Enriched Genes Are Individually Not Essential for Female Fertility in Mice. | 1.75e-08 | 30 | 94 | 5 | 38786026 | |
| Pubmed | 1.87e-08 | 167 | 94 | 8 | 22159717 | ||
| Pubmed | 1.91e-08 | 3 | 94 | 3 | 17767505 | ||
| Pubmed | 1.91e-08 | 3 | 94 | 3 | 2173707 | ||
| Pubmed | 1.91e-08 | 3 | 94 | 3 | 17289261 | ||
| Pubmed | LSM14B is essential for oocyte meiotic maturation by regulating maternal mRNA storage and clearance. | 2.46e-08 | 32 | 94 | 5 | 37889087 | |
| Pubmed | 4.12e-08 | 71 | 94 | 6 | 33541421 | ||
| Pubmed | 6.68e-08 | 15 | 94 | 4 | 20188150 | ||
| Pubmed | 6.68e-08 | 15 | 94 | 4 | 24453333 | ||
| Pubmed | Heparin/heparan sulfate controls fibrillin-1, -2 and -3 self-interactions in microfibril assembly. | 7.63e-08 | 4 | 94 | 3 | 25034023 | |
| Pubmed | 7.63e-08 | 4 | 94 | 3 | 23484127 | ||
| Pubmed | 7.63e-08 | 4 | 94 | 3 | 12429738 | ||
| Pubmed | 1.63e-07 | 46 | 94 | 5 | 17287250 | ||
| Pubmed | 1.90e-07 | 5 | 94 | 3 | 19047013 | ||
| Pubmed | 1.90e-07 | 5 | 94 | 3 | 16101684 | ||
| Pubmed | Multiple functions of the integrin alpha6beta4 in epidermal homeostasis and tumorigenesis. | 1.90e-07 | 5 | 94 | 3 | 16581764 | |
| Pubmed | 1.90e-07 | 5 | 94 | 3 | 31663850 | ||
| Pubmed | 1.90e-07 | 5 | 94 | 3 | 34411563 | ||
| Pubmed | DUX is a non-essential synchronizer of zygotic genome activation. | 2.49e-07 | 50 | 94 | 5 | 31806660 | |
| Pubmed | 4.26e-07 | 23 | 94 | 4 | 18971422 | ||
| Pubmed | 5.13e-07 | 175 | 94 | 7 | 28071719 | ||
| Pubmed | 5.78e-07 | 59 | 94 | 5 | 11279525 | ||
| Pubmed | 6.64e-07 | 7 | 94 | 3 | 12169628 | ||
| Pubmed | 1.06e-06 | 8 | 94 | 3 | 28330839 | ||
| Pubmed | TBX1 is required for normal stria vascularis and semicircular canal development. | 1.49e-06 | 31 | 94 | 4 | 31550482 | |
| Pubmed | 1.59e-06 | 9 | 94 | 3 | 12122015 | ||
| Pubmed | 1.59e-06 | 9 | 94 | 3 | 16382099 | ||
| Pubmed | 1.59e-06 | 9 | 94 | 3 | 20005821 | ||
| Pubmed | 1.59e-06 | 9 | 94 | 3 | 38844137 | ||
| Pubmed | ALDH1B1 is a potential stem/progenitor marker for multiple pancreas progenitor pools. | 3.11e-06 | 11 | 94 | 3 | 23142317 | |
| Pubmed | 3.11e-06 | 11 | 94 | 3 | 18809727 | ||
| Pubmed | Maternal Transient Receptor Potential Vanilloid 6 (Trpv6) Is Involved In Offspring Bone Development. | 3.44e-06 | 38 | 94 | 4 | 30786075 | |
| Pubmed | Comprehensive proteomic characterization of stem cell-derived extracellular matrices. | 3.79e-06 | 86 | 94 | 5 | 28327460 | |
| Pubmed | 3.89e-06 | 153 | 94 | 6 | 25037231 | ||
| Pubmed | ESCPE-1 mediates retrograde endosomal sorting of the SARS-CoV-2 host factor Neuropilin-1. | NPC1 COL4A4 FBLN1 FBN1 FBN2 LRP1 LAMB2 LAMC3 LTBP1 ZDHHC13 ITGB4 SPINK6 LRP8 SORL1 | 4.22e-06 | 1201 | 94 | 14 | 35696571 |
| Pubmed | FOXD1 is required for 3D patterning of the kidney interstitial matrix. | 5.36e-06 | 13 | 94 | 3 | 36335435 | |
| Pubmed | 5.36e-06 | 13 | 94 | 3 | 12682087 | ||
| Pubmed | Stage-specific association of apolipoprotein A-I and E in developing mouse retina. | 6.81e-06 | 14 | 94 | 3 | 17389516 | |
| Pubmed | 7.23e-06 | 2 | 94 | 2 | 12399449 | ||
| Pubmed | 7.23e-06 | 2 | 94 | 2 | 21851253 | ||
| Pubmed | 7.23e-06 | 2 | 94 | 2 | 25277766 | ||
| Pubmed | 7.23e-06 | 2 | 94 | 2 | 19907020 | ||
| Pubmed | New Evidence Supporting the Role of FBN1 in the Development of Adolescent Idiopathic Scoliosis. | 7.23e-06 | 2 | 94 | 2 | 30044367 | |
| Pubmed | Material and mechanical properties of bones deficient for fibrillin-1 or fibrillin-2 microfibrils. | 7.23e-06 | 2 | 94 | 2 | 21440062 | |
| Pubmed | 7.23e-06 | 2 | 94 | 2 | 15131124 | ||
| Pubmed | Loss of apolipoprotein E receptor LR11 in Alzheimer disease. | 7.23e-06 | 2 | 94 | 2 | 15313836 | |
| Pubmed | Differential glycosylation regulates processing of lipoprotein receptors by gamma-secretase. | 7.23e-06 | 2 | 94 | 2 | 12871934 | |
| Pubmed | 7.23e-06 | 2 | 94 | 2 | 1281468 | ||
| Pubmed | Microfibril structure masks fibrillin-2 in postnatal tissues. | 7.23e-06 | 2 | 94 | 2 | 20404337 | |
| Pubmed | 7.23e-06 | 2 | 94 | 2 | 22961762 | ||
| Pubmed | The N-Terminal Region of Fibrillin-1 Mediates a Bipartite Interaction with LTBP1. | 7.23e-06 | 2 | 94 | 2 | 28669633 | |
| Pubmed | 7.23e-06 | 2 | 94 | 2 | 21054386 | ||
| Pubmed | Retinoic acid coordinates somitogenesis and left-right patterning in vertebrate embryos. | 7.23e-06 | 2 | 94 | 2 | 15889094 | |
| Pubmed | Fibrillln mutations in Marfan syndrome and related phenotypes. | 7.23e-06 | 2 | 94 | 2 | 8791520 | |
| Pubmed | Fibrillin genes map to regions of conserved mouse/human synteny on mouse chromosomes 2 and 18. | 7.23e-06 | 2 | 94 | 2 | 8307578 | |
| Pubmed | Voltage-Gated Cav1 Channels in Disorders of Vision and Hearing. | 7.23e-06 | 2 | 94 | 2 | 25966695 | |
| Pubmed | Developmental expression of fibrillin genes suggests heterogeneity of extracellular microfibrils. | 7.23e-06 | 2 | 94 | 2 | 7744963 | |
| Pubmed | 7.23e-06 | 2 | 94 | 2 | 26408953 | ||
| Pubmed | 7.23e-06 | 2 | 94 | 2 | 24086669 | ||
| Pubmed | Arg-Gly-Asp-containing domains of fibrillins-1 and -2 distinctly regulate lung fibroblast migration. | 7.23e-06 | 2 | 94 | 2 | 18006876 | |
| Pubmed | 7.23e-06 | 2 | 94 | 2 | 11726670 | ||
| Pubmed | Differential zinc permeation and blockade of L-type Ca2+ channel isoforms Cav1.2 and Cav1.3. | 7.23e-06 | 2 | 94 | 2 | 26049024 | |
| Pubmed | Rare variants in FBN1 and FBN2 are associated with severe adolescent idiopathic scoliosis. | 7.23e-06 | 2 | 94 | 2 | 24833718 | |
| Pubmed | 7.23e-06 | 2 | 94 | 2 | 31077021 | ||
| Pubmed | 7.23e-06 | 2 | 94 | 2 | 19225208 | ||
| Pubmed | 7.23e-06 | 2 | 94 | 2 | 21697390 | ||
| Pubmed | Exome sequencing identified new mutations in a Marfan syndrome family. | 7.23e-06 | 2 | 94 | 2 | 24484584 | |
| Pubmed | Ca1.2 and CaV1.3 neuronal L-type calcium channels: differential targeting and signaling to pCREB. | 7.23e-06 | 2 | 94 | 2 | 16706838 | |
| Pubmed | 7.23e-06 | 2 | 94 | 2 | 26315408 | ||
| Pubmed | 7.23e-06 | 2 | 94 | 2 | 23761887 | ||
| Pubmed | 7.23e-06 | 2 | 94 | 2 | 14981074 | ||
| Pubmed | CaV1.2 and CaV1.3 channel hyperactivation in mouse islet β cells exposed to type 1 diabetic serum. | 7.23e-06 | 2 | 94 | 2 | 25292336 | |
| Pubmed | 7.23e-06 | 2 | 94 | 2 | 23963449 | ||
| Pubmed | 7.23e-06 | 2 | 94 | 2 | 24265020 | ||
| Pubmed | 7.23e-06 | 2 | 94 | 2 | 20529844 | ||
| Pubmed | 7.23e-06 | 2 | 94 | 2 | 17526649 | ||
| Pubmed | Mechanisms Responsible for ω-Pore Currents in Cav Calcium Channel Voltage-Sensing Domains. | 7.23e-06 | 2 | 94 | 2 | 28978442 | |
| Pubmed | 7.23e-06 | 2 | 94 | 2 | 12606379 | ||
| Interaction | ZFP41 interactions | 4.47e-09 | 57 | 86 | 7 | int:ZFP41 | |
| Interaction | NTN5 interactions | 5.02e-08 | 24 | 86 | 5 | int:NTN5 | |
| Interaction | PRAMEF4 interactions | 7.50e-08 | 3 | 86 | 3 | int:PRAMEF4 | |
| Interaction | IGFL3 interactions | 8.05e-07 | 75 | 86 | 6 | int:IGFL3 | |
| Interaction | PRAMEF5 interactions | 4.14e-06 | 8 | 86 | 3 | int:PRAMEF5 | |
| Interaction | FBLN2 interactions | 9.16e-06 | 66 | 86 | 5 | int:FBLN2 | |
| Interaction | ZDHHC15 interactions | 1.58e-05 | 125 | 86 | 6 | int:ZDHHC15 | |
| Interaction | PRAMEF15 interactions | 1.80e-05 | 2 | 86 | 2 | int:PRAMEF15 | |
| Interaction | SCN3A interactions | 4.04e-05 | 16 | 86 | 3 | int:SCN3A | |
| Interaction | FBN1 interactions | 6.63e-05 | 51 | 86 | 4 | int:FBN1 | |
| Interaction | DEFB125 interactions | 8.12e-05 | 20 | 86 | 3 | int:DEFB125 | |
| Interaction | ZNF224 interactions | 8.12e-05 | 20 | 86 | 3 | int:ZNF224 | |
| Interaction | CACNA1D interactions | 1.42e-04 | 24 | 86 | 3 | int:CACNA1D | |
| Interaction | CACNA1A interactions | 1.83e-04 | 123 | 86 | 5 | int:CACNA1A | |
| Interaction | EFEMP1 interactions | 1.83e-04 | 123 | 86 | 5 | int:EFEMP1 | |
| Cytoband | 1p36.21 | 6.05e-11 | 63 | 94 | 7 | 1p36.21 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr1p36 | PRAMEF25 PRAMEF5 PRAMEF9 PRAMEF15 PRAMEF4 PRAMEF27 PRAMEF11 PRAMEF6 | 8.17e-05 | 681 | 94 | 8 | chr1p36 |
| Cytoband | 3p14.3 | 1.74e-03 | 30 | 94 | 2 | 3p14.3 | |
| Cytoband | 1q23.1 | 4.05e-03 | 46 | 94 | 2 | 1q23.1 | |
| Cytoband | 11q11 | 4.22e-03 | 47 | 94 | 2 | 11q11 | |
| Cytoband | 19p13.1 | 4.40e-03 | 48 | 94 | 2 | 19p13.1 | |
| Cytoband | 11q12.1 | 4.49e-03 | 161 | 94 | 3 | 11q12.1 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr11q12 | 5.62e-03 | 345 | 94 | 4 | chr11q12 | |
| GeneFamily | PRAME family | PRAMEF25 PRAMEF5 PRAMEF9 PRAMEF15 PRAMEF4 PRAMEF27 PRAMEF11 PRAMEF6 | 6.42e-14 | 24 | 79 | 8 | 686 |
| GeneFamily | Aldehyde dehydrogenases | 1.24e-06 | 19 | 79 | 4 | 398 | |
| GeneFamily | Olfactory receptors, family 9 | 2.81e-06 | 23 | 79 | 4 | 156 | |
| GeneFamily | Calcium voltage-gated channel subunits | 4.69e-06 | 26 | 79 | 4 | 253 | |
| GeneFamily | Low density lipoprotein receptors | 2.23e-05 | 13 | 79 | 3 | 634 | |
| GeneFamily | Collagens | 1.06e-03 | 46 | 79 | 3 | 490 | |
| GeneFamily | Laminin subunits | 1.21e-03 | 12 | 79 | 2 | 626 | |
| GeneFamily | Septins | 1.43e-03 | 13 | 79 | 2 | 732 | |
| GeneFamily | Myotubularins|Phosphoinositide phosphatases | 1.91e-03 | 15 | 79 | 2 | 903 | |
| Coexpression | NABA_CORE_MATRISOME | COL4A4 FBLN1 THBS4 COL11A2 FBN1 FBN2 VCAN LAMB2 COL5A3 LAMC3 LTBP1 FBN3 | 2.41e-10 | 275 | 92 | 12 | M5884 |
| Coexpression | NABA_CORE_MATRISOME | COL4A4 FBLN1 THBS4 COL11A2 FBN1 FBN2 VCAN LAMB2 COL5A3 LAMC3 LTBP1 | 2.91e-09 | 270 | 92 | 11 | MM17057 |
| Coexpression | MIKKELSEN_ES_ICP_WITH_H3K4ME3 | ZMAT5 LIPA PRAMEF5 CRYGN TLR2 PRAMEF15 TRPV2 LRP1 LAMB2 COL5A3 PRAMEF4 MEAK7 PRAMEF27 ABCC6 PRAMEF11 PRAMEF6 | 2.00e-08 | 807 | 92 | 16 | MM855 |
| Coexpression | INGRAM_SHH_TARGETS_UP | FBN1 PRAMEF5 FBN2 PRAMEF15 PRAMEF4 PRAMEF27 PRAMEF11 PRAMEF6 | 8.01e-08 | 156 | 92 | 8 | MM550 |
| Coexpression | KINNEY_DNMT1_METHYLATION_TARGETS | 1.23e-07 | 34 | 92 | 5 | MM955 | |
| Coexpression | YAMAZAKI_TCEB3_TARGETS_DN | PRAMEF5 PRAMEF15 G2E3 PRAMEF4 ALDH2 PRAMEF27 PRAMEF11 PRAMEF6 SORL1 | 1.31e-07 | 232 | 92 | 9 | MM1019 |
| Coexpression | KOHOUTEK_CCNT2_TARGETS | 4.16e-07 | 81 | 92 | 6 | MM938 | |
| Coexpression | NABA_ECM_GLYCOPROTEINS | 4.61e-07 | 196 | 92 | 8 | M3008 | |
| Coexpression | MIKKELSEN_NPC_ICP_WITH_H3K4ME3 | ZMAT5 LIPA PRAMEF5 TLR2 PRAMEF15 LRP1 LAMB2 PRAMEF4 MEAK7 PRAMEF11 PRAMEF6 | 1.38e-06 | 497 | 92 | 11 | MM863 |
| Coexpression | YAUCH_HEDGEHOG_SIGNALING_PARACRINE_DN | COL4A4 THBS4 PRAMEF5 PRAMEF15 LAMC3 PRAMEF4 PRAMEF11 RYR2 PRAMEF6 | 1.44e-06 | 309 | 92 | 9 | MM1244 |
| Coexpression | MEISSNER_BRAIN_HCP_WITH_H3_UNMETHYLATED | 1.73e-06 | 57 | 92 | 5 | MM1262 | |
| Coexpression | NABA_MATRISOME | COL4A4 FBLN1 THBS4 COL11A2 FBN1 FBN2 VCAN LAMB2 COL5A3 LAMC3 LTBP1 ADAMTS14 MUC6 ANGPTL5 FBN3 | 2.74e-06 | 1026 | 92 | 15 | M5889 |
| Coexpression | BYSTRYKH_HEMATOPOIESIS_STEM_CELL_AND_BRAIN_QTL_TRANS | 3.43e-06 | 180 | 92 | 7 | MM612 | |
| Coexpression | NABA_ECM_GLYCOPROTEINS | 5.08e-06 | 191 | 92 | 7 | MM17059 | |
| Coexpression | GSE17721_LPS_VS_POLYIC_8H_BMDC_DN | 6.64e-06 | 199 | 92 | 7 | M3813 | |
| Coexpression | DESCARTES_FETAL_THYMUS_STROMAL_CELLS | 9.01e-06 | 137 | 92 | 6 | M40313 | |
| Coexpression | GAO_LARGE_INTESTINE_ADULT_CJ_IMMUNE_CELLS | FBLN1 FBN1 VCAN TRPV2 LRP1 LAMB2 COL5A3 LAMC3 ALDH1A3 ADGRL3 | 1.13e-05 | 505 | 92 | 10 | M39167 |
| Coexpression | HAN_SATB1_TARGETS_UP | 1.89e-05 | 425 | 92 | 9 | M9639 | |
| Coexpression | MORI_SMALL_PRE_BII_LYMPHOCYTE_UP | 2.51e-05 | 98 | 92 | 5 | MM592 | |
| Coexpression | DESCARTES_ORGANOGENESIS_SCHWANN_CELL_PRECURSOR | 2.51e-05 | 98 | 92 | 5 | MM3656 | |
| Coexpression | HUANG_GATA2_TARGETS_DN | 2.51e-05 | 98 | 92 | 5 | MM942 | |
| Coexpression | HEVNER_TELENCEPHALON_MENINGEAL_CELLS | 2.89e-05 | 50 | 92 | 4 | MM403 | |
| Coexpression | MEISSNER_NPC_HCP_WITH_H3_UNMETHYLATED | TMEM171 CLDN11 THBS4 PRAMEF5 PRAMEF15 LAMC3 PRAMEF4 ITGB4 PRAMEF11 PRAMEF6 | 3.38e-05 | 574 | 92 | 10 | MM820 |
| Coexpression | NABA_MATRISOME | COL4A4 FBLN1 THBS4 COL11A2 FBN1 FBN2 VCAN LAMB2 COL5A3 LAMC3 LTBP1 ADAMTS14 MUC6 | 4.99e-05 | 1008 | 92 | 13 | MM17056 |
| Coexpression | MEK_UP.V1_UP | 6.58e-05 | 195 | 92 | 6 | M2725 | |
| Coexpression | GSE4984_GALECTIN1_VS_VEHICLE_CTRL_TREATED_DC_DN | 7.36e-05 | 199 | 92 | 6 | M6507 | |
| Coexpression | GSE24634_TEFF_VS_TCONV_DAY3_IN_CULTURE_DN | 7.57e-05 | 200 | 92 | 6 | M4616 | |
| Coexpression | HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION | 7.57e-05 | 200 | 92 | 6 | M5930 | |
| Coexpression | TRAVAGLINI_LUNG_ADVENTITIAL_FIBROBLAST_CELL | 8.42e-05 | 296 | 92 | 7 | M41675 | |
| Coexpression | SESTO_RESPONSE_TO_UV_C8 | 1.15e-04 | 71 | 92 | 4 | M2948 | |
| Coexpression | FOSTER_KDM1A_TARGETS_UP | 1.29e-04 | 317 | 92 | 7 | MM956 | |
| Coexpression | FARMER_BREAST_CANCER_APOCRINE_VS_LUMINAL | 1.56e-04 | 327 | 92 | 7 | M4008 | |
| Coexpression | HELLEBREKERS_SILENCED_DURING_TUMOR_ANGIOGENESIS | 1.58e-04 | 77 | 92 | 4 | M19128 | |
| Coexpression | CHICAS_RB1_TARGETS_CONFLUENT | 1.72e-04 | 567 | 92 | 9 | M2129 | |
| Coexpression | DELYS_THYROID_CANCER_DN | 1.74e-04 | 233 | 92 | 6 | M13273 | |
| Coexpression | HEBERT_MATRISOME_TNBC_LUNG_METASTASIS_TUMOR_CELL_DERIVED | 1.81e-04 | 6 | 92 | 2 | M48000 | |
| Coexpression | ONDER_CDH1_SIGNALING_VIA_CTNNB1 | 2.21e-04 | 84 | 92 | 4 | M15484 | |
| Coexpression | HESS_TARGETS_OF_HOXA9_AND_MEIS1_DN | 2.21e-04 | 84 | 92 | 4 | M14829 | |
| Coexpression | SANSOM_APC_TARGETS | 2.29e-04 | 245 | 92 | 6 | MM735 | |
| Coexpression | BYSTRYKH_HEMATOPOIESIS_STEM_CELL_QTL_TRANS | COL4A4 CACNA1S FBLN1 ALDH1A2 PRAMEF5 PRAMEF15 MYNN PRAMEF4 PRAMEF11 PRAMEF6 LRP8 | 2.37e-04 | 871 | 92 | 11 | MM1005 |
| Coexpression | MIKKELSEN_ES_ICP_WITH_H3K4ME3 | 2.38e-04 | 728 | 92 | 10 | M2004 | |
| Coexpression | CLASPER_LYMPHATIC_VESSELS_DURING_METASTASIS_DN | 2.52e-04 | 35 | 92 | 3 | M11788 | |
| Coexpression | CLASPER_LYMPHATIC_VESSELS_DURING_METASTASIS_DN | 2.75e-04 | 36 | 92 | 3 | MM1212 | |
| Coexpression | HESS_TARGETS_OF_HOXA9_AND_MEIS1_DN | 3.69e-04 | 96 | 92 | 4 | MM1009 | |
| Coexpression | NABA_BASEMENT_MEMBRANES | 3.76e-04 | 40 | 92 | 3 | M5887 | |
| Coexpression | HU_FETAL_RETINA_FIBROBLAST | 4.19e-04 | 385 | 92 | 7 | M39264 | |
| Coexpression | NABA_COLLAGENS | 4.66e-04 | 43 | 92 | 3 | MM17060 | |
| Coexpression | GSE21360_NAIVE_VS_PRIMARY_MEMORY_CD8_TCELL_DN | 4.73e-04 | 183 | 92 | 5 | M7627 | |
| CoexpressionAtlas | dev gonad_e12.5_F_VasAssMesen_MafB_top-relative-expression-ranked_500 | ADM CACNA1D TMEM171 ALDH1A2 FBN1 FBN2 VCAN LRP1 LTBP1 ADGRL3 RYR2 | 1.71e-07 | 388 | 78 | 11 | gudmap_dev gonad_e12.5_F_VasAssMesen_MafB_500 |
| CoexpressionAtlas | dev gonad_e13.5_F_VascAssocMesenchStromOvary_Sma_top-relative-expression-ranked_1000 | NPC1 ADM CACNA1D TTC8 FBLN1 ALDH1A2 FBN1 FBN2 KIF26B VCAN LRP1 ADGRL3 RYR2 MOV10 | 1.08e-06 | 797 | 78 | 14 | gudmap_dev gonad_e13.5_F_VascAssocMesenchStromOvary_Sma_1000 |
| CoexpressionAtlas | dev gonad_e11.5_M_GonadVasMes_Flk_k-means-cluster#1_top-relative-expression-ranked_1000 | 4.00e-06 | 337 | 78 | 9 | gudmap_dev gonad_e11.5_M_GonadVasMes_Flk_k1_1000 | |
| CoexpressionAtlas | dev gonad_e12.5_F_VasAssMesen_MafB_top-relative-expression-ranked_1000 | ADM CACNA1D TMEM171 FUT10 ALDH1A2 FBN1 FBN2 VCAN LRP1 LTBP1 ADGRL3 RYR2 MOV10 | 5.08e-06 | 783 | 78 | 13 | gudmap_dev gonad_e12.5_F_VasAssMesen_MafB_1000 |
| CoexpressionAtlas | dev gonad_e13.5_F_VascAssocMesenchStromOvary_MafB_top-relative-expression-ranked_500 | 6.38e-06 | 357 | 78 | 9 | gudmap_dev gonad_e13.5_F_VascAssocMesenchStromOvary_MafB_500 | |
| CoexpressionAtlas | kidney_P2_CapMes_Crym_k-means-cluster#3_top-relative-expression-ranked_500 | 9.48e-06 | 202 | 78 | 7 | gudmap_kidney_P2_CapMes_Crym_k3_500 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e13.5_bladder mesenchyme_emap-3087_top-relative-expression-ranked_1000 | FUT10 FBLN1 LRR1 THBS4 ALDH1A2 FBN2 KIF26B VCAN TRPV2 LTBP1 MYNN RYR2 NSD3 | 1.04e-05 | 837 | 78 | 13 | gudmap_developingLowerUrinaryTract_e13.5_bladder mesenchyme_1000 |
| CoexpressionAtlas | dev gonad_e12.5_F_SupCellPrec_Sry_top-relative-expression-ranked_100 | 1.45e-05 | 84 | 78 | 5 | gudmap_dev gonad_e12.5_F_SupCellPrec_Sry_100 | |
| CoexpressionAtlas | dev gonad_e13.5_F_VascAssocMesenchStromOvary_MafB_top-relative-expression-ranked_1000 | NPC1 CACNA1D TMEM171 ALDH1A2 FBN1 FBN2 VCAN LRP1 LTBP1 ADGRL3 RYR2 MOV10 | 1.55e-05 | 740 | 78 | 12 | gudmap_dev gonad_e13.5_F_VascAssocMesenchStromOvary_MafB_1000 |
| CoexpressionAtlas | dev gonad_e12.5_F_VasAssMesen_MafB_k-means-cluster#4_top-relative-expression-ranked_500 | 1.63e-05 | 146 | 78 | 6 | gudmap_dev gonad_e12.5_F_VasAssMesen_MafB_k4_500 | |
| CoexpressionAtlas | dev gonad_e12.5_M_InterstitTestis_Sma_k-means-cluster#4_top-relative-expression-ranked_200 | 1.70e-05 | 42 | 78 | 4 | gudmap_dev gonad_e12.5_M_InterstitTestis_Sma_k4_200 | |
| CoexpressionAtlas | dev gonad_e12.5_M_InterstitTestis_Sma_top-relative-expression-ranked_200 | 2.12e-05 | 153 | 78 | 6 | gudmap_dev gonad_e12.5_M_InterstitTestis_Sma_200 | |
| CoexpressionAtlas | dev gonad_e11.5_F_GonadVasMes_Flk_top-relative-expression-ranked_500 | 2.46e-05 | 423 | 78 | 9 | gudmap_dev gonad_e11.5_F_GonadVasMes_Flk_500 | |
| CoexpressionAtlas | kidney_P4_CapMesRenVes_Crym_k-means-cluster#1_top-relative-expression-ranked_200 | 2.67e-05 | 47 | 78 | 4 | gudmap_kidney_P4_CapMesRenVes_Crym_k1_200 | |
| CoexpressionAtlas | dev gonad_e12.5_F_VasAssocMesStromOvary_Sma_top-relative-expression-ranked_1000 | NPC1 ADM TTC8 ALDH1A2 FBN1 FBN2 KIF26B VCAN LRP1 ADGRL3 RYR2 MOV10 | 3.21e-05 | 797 | 78 | 12 | gudmap_dev gonad_e12.5_F_VasAssocMesStromOvary_Sma_1000 |
| CoexpressionAtlas | dev lower uro neuro_e15.5_PelvicGanglion_Sox10_k-means-cluster#4_top-relative-expression-ranked_1000 | 4.91e-05 | 261 | 78 | 7 | gudmap_dev lower uro neuro_e15.5_PelvicGanglion_Sox10_k4_1000 | |
| CoexpressionAtlas | dev gonad_e13.5_F_VascAssocMesenchStromOvary_Sma_top-relative-expression-ranked_500 | 6.63e-05 | 372 | 78 | 8 | gudmap_dev gonad_e13.5_F_VascAssocMesenchStromOvary_Sma_500 | |
| CoexpressionAtlas | dev gonad_e12.5_F_VasAssocMesStromOvary_Sma_top-relative-expression-ranked_500 | 8.42e-05 | 385 | 78 | 8 | gudmap_dev gonad_e12.5_F_VasAssocMesStromOvary_Sma_500 | |
| CoexpressionAtlas | dev gonad_e13.5_F_VascAssocMesenchStromOvary_MafB_k-means-cluster#3_top-relative-expression-ranked_500 | 8.71e-05 | 122 | 78 | 5 | gudmap_dev gonad_e13.5_F_VascAssocMesenchStromOvary_MafB_k3_500 | |
| CoexpressionAtlas | kidney_P2_CapMes_Crym_top-relative-expression-ranked_500 | 9.72e-05 | 291 | 78 | 7 | gudmap_kidney_P2_CapMes_Crym_500 | |
| CoexpressionAtlas | dev gonad_e11.5_M_GonadVasMes_Flk_k-means-cluster#4_top-relative-expression-ranked_500 | 1.14e-04 | 207 | 78 | 6 | gudmap_dev gonad_e11.5_M_GonadVasMes_Flk_k4_500 | |
| CoexpressionAtlas | dev gonad_e12.5_M_InterstitLeydig_MafB_k-means-cluster#1_top-relative-expression-ranked_1000 | 1.44e-04 | 310 | 78 | 7 | gudmap_dev gonad_e12.5_M_InterstitLeydig_MafB_k1_1000 | |
| CoexpressionAtlas | dev gonad_e13.5_F_SupCellPrec_Sry_top-relative-expression-ranked_1000 | NPC1 ADM CACNA1D TMEM171 ALDH1A2 FBN2 ALDH2 PDE10A ADGRL3 RYR2 MOV10 | 1.65e-04 | 804 | 78 | 11 | gudmap_dev gonad_e13.5_F_SupCellPrec_Sry_1000 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30892_top-relative-expression-ranked_1000 | CACNA1D CLDN11 THBS4 ALDH1A2 KIF26B VCAN TRPV2 MYNN ADGRL3 NSD3 SORL1 | 1.68e-04 | 806 | 78 | 11 | gudmap_developingLowerUrinaryTract_e14.5_ urethra_1000 |
| CoexpressionAtlas | dev gonad_e13.5_F_SupCellPrec_Sry_top-relative-expression-ranked_100 | 1.96e-04 | 78 | 78 | 4 | gudmap_dev gonad_e13.5_F_SupCellPrec_Sry_100 | |
| CoexpressionAtlas | dev gonad_e11.5_F_GonMes_Sma_k-means-cluster#4_top-relative-expression-ranked_1000 | 2.00e-04 | 327 | 78 | 7 | gudmap_dev gonad_e11.5_F_GonMes_Sma_k4_1000 | |
| CoexpressionAtlas | dev gonad_e11.5_M_GonadVasMes_Flk_top-relative-expression-ranked_1000 | TTC8 TMEM171 FBLN1 ALDH1A2 FBN1 FBN2 KIF26B VCAN LRP1 LTBP1 ADGRL3 | 2.10e-04 | 827 | 78 | 11 | gudmap_dev gonad_e11.5_M_GonadVasMes_Flk_1000 |
| CoexpressionAtlas | thyroid gland | 2.55e-04 | 240 | 78 | 6 | thyroid gland | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-5517_top-relative-expression-ranked_100 | 2.85e-04 | 86 | 78 | 4 | gudmap_developingLowerUrinaryTract_e14.5_ urogenital sinus_100 | |
| CoexpressionAtlas | dev gonad_e11.5_F_GonMes_Sma_top-relative-expression-ranked_1000 | ADM TMEM171 FBLN1 ALDH1A2 FBN1 KIF26B VCAN LRP1 LTBP1 ADGRL3 RYR2 | 2.88e-04 | 858 | 78 | 11 | gudmap_dev gonad_e11.5_F_GonMes_Sma_1000 |
| CoexpressionAtlas | facebase_RNAseq_e14.5_palate_poster_distal_ERK2_WT_2500_K1 | CACNA1C TTC8 FBN1 FBN2 STAG1 KIF26B VCAN TLR2 LTBP1 PDE10A MEAK7 ADGRL3 LRP8 | 3.04e-04 | 1166 | 78 | 13 | facebase_RNAseq_e14.5_palate_poster_distal_ERK2_WT_2500_K1 |
| CoexpressionAtlas | dev gonad_e11.5_F_GonadVasMes_Flk_k-means-cluster#3_top-relative-expression-ranked_1000 | 3.23e-04 | 354 | 78 | 7 | gudmap_dev gonad_e11.5_F_GonadVasMes_Flk_k3_1000 | |
| CoexpressionAtlas | dev gonad_e13.5_F_SupCellPrec_Sry_top-relative-expression-ranked_200 | 3.56e-04 | 165 | 78 | 5 | gudmap_dev gonad_e13.5_F_SupCellPrec_Sry_200 | |
| CoexpressionAtlas | dev gonad_e12.5_F_SupCellPrec_Sry_top-relative-expression-ranked_200 | 3.56e-04 | 165 | 78 | 5 | gudmap_dev gonad_e12.5_F_SupCellPrec_Sry_200 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-5517_top-relative-expression-ranked_200 | 3.66e-04 | 166 | 78 | 5 | gudmap_developingLowerUrinaryTract_e14.5_ urogenital sinus_200 | |
| CoexpressionAtlas | dev gonad_e13.5_F_VascAssocMesenchStromOvary_Sma_k-means-cluster#4_top-relative-expression-ranked_1000 | 3.87e-04 | 168 | 78 | 5 | gudmap_dev gonad_e13.5_F_VascAssocMesenchStromOvary_Sma_k4_1000 | |
| CoexpressionAtlas | kidney_P4_CapMesRenVes_Crym_k-means-cluster#4_top-relative-expression-ranked_500 | 4.16e-04 | 95 | 78 | 4 | gudmap_kidney_P4_CapMesRenVes_Crym_k4_500 | |
| CoexpressionAtlas | Progenitor-Cell-Biology-Consortium_reference_CardiacMyocyte_top-relative-expression-ranked_500 | 4.51e-04 | 493 | 78 | 8 | PCBC_ctl_CardiacMyocyte_500 | |
| CoexpressionAtlas | kidney single cell_e11.5_MetanephMesench_StemCellamp_k-means-cluster#3_top-relative-expression-ranked_1000 | 4.91e-04 | 177 | 78 | 5 | gudmap_kidney single cell_e11.5_MetanephMesench_Scamp_k3_1000 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e13.5_bladder mesenchyme_emap-3087_k-means-cluster#1_top-relative-expression-ranked_1000 | 5.25e-04 | 101 | 78 | 4 | gudmap_developingLowerUrinaryTract_e13.5_bladder mesenchyme_1000_k1 | |
| CoexpressionAtlas | kidney_P1_CapMes_Crym_k-means-cluster#1_top-relative-expression-ranked_1000 | 6.79e-04 | 401 | 78 | 7 | gudmap_kidney_P1_CapMes_Crym_k1_1000 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30892_top-relative-expression-ranked_500 | 7.40e-04 | 407 | 78 | 7 | gudmap_developingLowerUrinaryTract_e14.5_ urethra_500 | |
| CoexpressionAtlas | kidney_P0_CapMes_Crym_k-means-cluster#2_top-relative-expression-ranked_500 | 7.44e-04 | 194 | 78 | 5 | gudmap_kidney_P0_CapMes_Crym_k2_500 | |
| CoexpressionAtlas | DevelopingKidney_e15.5_Ureteral Smooth Musc_emap-28812_k-means-cluster#4_top-relative-expression-ranked_1000 | 7.61e-04 | 195 | 78 | 5 | gudmap_developingKidney_e15.5_Ureteral Smooth Musc_1000_k4 | |
| CoexpressionAtlas | kidney_P1_CapMes_Crym_k-means-cluster#4_top-relative-expression-ranked_500 | 7.79e-04 | 196 | 78 | 5 | gudmap_kidney_P1_CapMes_Crym_k4_500 | |
| CoexpressionAtlas | Progenitor-Cell-Biology-Consortium_reference_CardiacMyocyte_top-relative-expression-ranked_1000 | ADM COL4A4 TMEM171 CLDN11 FBN1 TRPV2 LRP1 COL5A3 ADAMTS14 ALDH1A3 PDE10A | 8.40e-04 | 975 | 78 | 11 | PCBC_ctl_CardiacMyocyte_1000 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-5517_top-relative-expression-ranked_500 | 8.42e-04 | 416 | 78 | 7 | gudmap_developingLowerUrinaryTract_e14.5_ urogenital sinus_500 | |
| CoexpressionAtlas | dev gonad_e11.5_M_GonadVasMes_Flk_top-relative-expression-ranked_500 | 8.65e-04 | 418 | 78 | 7 | gudmap_dev gonad_e11.5_M_GonadVasMes_Flk_500 | |
| CoexpressionAtlas | DevelopingKidney_e15.5_Pelvic Mesenchyme_emap-8241_k-means-cluster#2_top-relative-expression-ranked_1000 | 9.02e-04 | 305 | 78 | 6 | gudmap_developingKidney_e15.5_Pelvic Mesenchyme_1000_k2 | |
| CoexpressionAtlas | dev gonad_e11.5_F_GonadVasMes_Flk_top-relative-expression-ranked_1000 | 9.04e-04 | 831 | 78 | 10 | gudmap_dev gonad_e11.5_F_GonadVasMes_Flk_1000 | |
| CoexpressionAtlas | dev gonad_e13.5_F_SupCellPrec_Sry_top-relative-expression-ranked_500 | 9.15e-04 | 422 | 78 | 7 | gudmap_dev gonad_e13.5_F_SupCellPrec_Sry_500 | |
| CoexpressionAtlas | dev gonad_e12.5_F_VasAssocMesStromOvary_Sma_k-means-cluster#1_top-relative-expression-ranked_200 | 9.26e-04 | 52 | 78 | 3 | gudmap_dev gonad_e12.5_F_VasAssocMesStromOvary_Sma_k1_200 | |
| CoexpressionAtlas | dev gonad_e13.5_M_InterstitFLeydig_MafB_k-means-cluster#2_top-relative-expression-ranked_500 | 9.26e-04 | 52 | 78 | 3 | gudmap_dev gonad_e13.5_M_InterstitFLeydig_MafB_k2_500 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-6689_top-relative-expression-ranked_500 | 9.80e-04 | 427 | 78 | 7 | DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-6689_500 | |
| CoexpressionAtlas | dev gonad_e11.5_M_GonMes_Sma_k-means-cluster#3_top-relative-expression-ranked_1000 | 9.98e-04 | 311 | 78 | 6 | gudmap_dev gonad_e11.5_M_GonMes_Sma_k3_1000 | |
| CoexpressionAtlas | Stromal Cells, Fi.Sk, gp38+ CD140a+, Skin, avg-4 | 1.12e-03 | 437 | 78 | 7 | GSM777046_500 | |
| CoexpressionAtlas | DevelopingKidney_e13.5_podocyte cells_emap-27773_top-relative-expression-ranked_1000 | CACNA1C FBLN1 CLDN11 THBS4 KIF26B TLR2 LTBP1 ALDH1A3 ADGRL3 LRP8 | 1.12e-03 | 855 | 78 | 10 | gudmap_developingKidney_e13.5_podocyte cells_1000 |
| CoexpressionAtlas | dev gonad_e12.5_F_VasAssocMesStromOvary_Sma_k-means-cluster#4_top-relative-expression-ranked_1000 | 1.17e-03 | 125 | 78 | 4 | gudmap_dev gonad_e12.5_F_VasAssocMesStromOvary_Sma_k4_1000 | |
| CoexpressionAtlas | dev lower uro neuro_e15.5_PelvicGanglion_Sox10_k-means-cluster#2_top-relative-expression-ranked_500 | 1.24e-03 | 127 | 78 | 4 | gudmap_dev lower uro neuro_e15.5_PelvicGanglion_Sox10_k2_500 | |
| CoexpressionAtlas | dev gonad_e12.5_M_InterstitTestis_Sma_k-means-cluster#2_top-relative-expression-ranked_500 | 1.35e-03 | 130 | 78 | 4 | gudmap_dev gonad_e12.5_M_InterstitTestis_Sma_k2_500 | |
| CoexpressionAtlas | dev gonad_e12.5_M_SertoliCell_Sox9_k-means-cluster#1_top-relative-expression-ranked_200 | 1.36e-03 | 15 | 78 | 2 | gudmap_dev gonad_e12.5_M_SertoliCell_Sox9_k1_200 | |
| CoexpressionAtlas | dev gonad_e11.5_F_SupCellPrec_Sry_k-means-cluster#1_top-relative-expression-ranked_200 | 1.40e-03 | 60 | 78 | 3 | gudmap_dev gonad_e11.5_F_SupCellPrec_Sry_k1_200 | |
| CoexpressionAtlas | dev lower uro neuro_e15.5_PelvicGanglion_Sox10_top-relative-expression-ranked_1000 | 1.45e-03 | 734 | 78 | 9 | gudmap_dev lower uro neuro_e15.5_PelvicGanglion_Sox10_1000 | |
| ToppCell | LPS-IL1RA-Stromal_mesenchymal-Matrix_Fibroblast-Activated_MatrixFB|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | CACNA1C CACNA1D FBLN1 ALDH1A2 KIF26B VCAN LRP1 ALDH1A3 PDE10A RYR2 | 7.59e-12 | 190 | 92 | 10 | 45df8fee00f8949937863159d7aa042e72748d9b |
| ToppCell | LPS_only-Stromal_mesenchymal-Matrix_Fibroblast-MatrixFB|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.16e-10 | 189 | 92 | 9 | 2a22b9fae70afb3dab8476f9c00e48a4df756410 | |
| ToppCell | LPS-IL1RA+antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-Activated_MatrixFB|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.38e-10 | 191 | 92 | 9 | b13229bb7f3713a392271aaf5dbae3edd1b9fe5a | |
| ToppCell | LPS-IL1RA-Stromal_mesenchymal-Matrix_Fibroblast|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.49e-10 | 192 | 92 | 9 | f4fc2b0121f879bab2bee99dfb5ff2c3ca1c0e1b | |
| ToppCell | LPS-IL1RA-Stromal_mesenchymal|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.49e-10 | 192 | 92 | 9 | 4e47a02007f562f29ba5910df64d32a0167d0bd1 | |
| ToppCell | LPS-IL1RA-Stromal_mesenchymal-Matrix_Fibroblast-MatrixFB|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.49e-10 | 192 | 92 | 9 | deeecd26972241846b4cb998edf0c7a87ff0c4df | |
| ToppCell | droplet-Pancreas-Exocrine-18m-Mesenchymal-pancreatic_stellate_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.29e-09 | 187 | 92 | 8 | 4e553721fa5598cb211f44e3226280b7e6885484 | |
| ToppCell | droplet-Pancreas-Exocrine-18m-Mesenchymal|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.29e-09 | 187 | 92 | 8 | d36e7fc6125e7a4310499365022d38f34b757a73 | |
| ToppCell | droplet-Pancreas-Exocrine-18m-Mesenchymal-pancreatic_stellate_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.29e-09 | 187 | 92 | 8 | 827eae63fabf6892a82ce7779b5f395958d3d628 | |
| ToppCell | E18.5-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF2|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 6.25e-09 | 191 | 92 | 8 | 4b50fdd310701251e64e16cd2d07ce03dbfd3e3e | |
| ToppCell | E18.5-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF2-AF2_mature|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 6.25e-09 | 191 | 92 | 8 | 75d2197076a9dfc868e8baf95bd4c5e44f438e3e | |
| ToppCell | facs-Pancreas-Exocrine-3m-Mesenchymal-pancreatic_stellate_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.51e-09 | 192 | 92 | 8 | 8937a59f6bbe07f671bdabbd3707dc9c17a14cd9 | |
| ToppCell | facs-Pancreas-Exocrine-3m-Mesenchymal|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.51e-09 | 192 | 92 | 8 | e4a7f2673f801b008ca67291db2fb2b9fd2955b8 | |
| ToppCell | LPS_only-Stromal_mesenchymal|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 6.51e-09 | 192 | 92 | 8 | 162d8b5858d150ecbbd1c9bf2b19c6c9cd50a158 | |
| ToppCell | facs-Pancreas-Exocrine-3m-Mesenchymal-pancreatic_stellate_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.51e-09 | 192 | 92 | 8 | ac1477433704573f95111eee6263b93668d2845e | |
| ToppCell | LPS_only-Stromal_mesenchymal-Matrix_Fibroblast|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 6.51e-09 | 192 | 92 | 8 | ee085e04d5dcfb657522484ed20b8c1ddeccfe0c | |
| ToppCell | droplet-Limb_Muscle-nan-18m-Mesenchymal-mesenchymal_stem_cell|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.78e-09 | 193 | 92 | 8 | 45b5cab4dfeb0ed3b13631db5963740a792b810f | |
| ToppCell | nucseq-Mesenchymal-Myocytic|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 7.06e-09 | 194 | 92 | 8 | 2d66091097e106c7bee22e5281f50724700bdf8d | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast-|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 7.06e-09 | 194 | 92 | 8 | 240d122dcb9dd1ab2867503ad85869853adcacae | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 7.06e-09 | 194 | 92 | 8 | ae7df037592f1c20c9d32be15fe6fc3c562ebeb1 | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-Activated_MatrixFB|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 7.06e-09 | 194 | 92 | 8 | 89b706af2b25991fc2707eb24f49ba6ff3ae01f7 | |
| ToppCell | COVID-19-lung-Fibroblast|COVID-19 / Disease (COVID-19 only), tissue and cell type | 8.28e-09 | 198 | 92 | 8 | 3ec01a55ade5e1627258cc3cfebb2c3207a4cb43 | |
| ToppCell | COVID-19-kidney-Fibroblast-2|kidney / Disease (COVID-19 only), tissue and cell type | 8.28e-09 | 198 | 92 | 8 | ca26ca460856b1faaa3e83766da6abdf63af2b51 | |
| ToppCell | LPS_IL1RA-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 8.62e-09 | 199 | 92 | 8 | a7dd94b172c973a131a6792f8ccd9bfe44d984ac | |
| ToppCell | Parenchymal-NucSeq-Stromal|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 8.96e-09 | 200 | 92 | 8 | cf433f9b43d7db07acaf70e060f8f77c974e72f3 | |
| ToppCell | Bronchial-NucSeq-Stromal-Fibroblastic|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 8.96e-09 | 200 | 92 | 8 | cae972324d1dfea6efeaf6013f265c7c6bb48db4 | |
| ToppCell | Parenchymal-NucSeq-Stromal-Fibroblastic|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 8.96e-09 | 200 | 92 | 8 | 311fab076f2ceb258e3970eb21e39344b894042a | |
| ToppCell | Bronchial-NucSeq-Stromal-Fibroblastic-Fibro_peribronchial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 8.96e-09 | 200 | 92 | 8 | fb53be20392a8309a7393774c774a1b1aec6e676 | |
| ToppCell | Tracheal-NucSeq-Stromal-Fibroblastic-Fibro_peribronchial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 8.96e-09 | 200 | 92 | 8 | 58b38f9a484ee94191091a0659ed62ebed2d4a14 | |
| ToppCell | TCGA-Bone_and_Soft_Tissue-Primary_Tumor-Sarcoma-Monophasic_Synovial_Sarcoma-5|TCGA-Bone_and_Soft_Tissue / Sample_Type by Project: Shred V9 | 4.09e-08 | 93 | 92 | 6 | 3e05ea0f8f4a7cdb78a596f47d563dc3c94d4d8e | |
| ToppCell | 343B-Fibroblasts-Fibroblast-A_(Fibroblast_progenitors)-|343B / Donor, Lineage, Cell class and subclass (all cells) | 8.23e-08 | 176 | 92 | 7 | 2e94bbe17c0bb65dc58b4ebc0cb829258bd7373b | |
| ToppCell | 343B-Fibroblasts-Fibroblast-A_(Fibroblast_progenitors)|343B / Donor, Lineage, Cell class and subclass (all cells) | 8.23e-08 | 176 | 92 | 7 | f33ab41d121b59d871ad7d48ca021524a027d2ef | |
| ToppCell | TCGA-Ovary-Primary_Tumor-Ovarian_Carcinoma-Serous_Cystadenocarcinoma-6|TCGA-Ovary / Sample_Type by Project: Shred V9 | 8.89e-08 | 178 | 92 | 7 | 142879e9393e721f9b05a6bb46995c9d6d713c95 | |
| ToppCell | Control-Stromal_mesenchymal-Matrix_Fibroblast-MatrixFB|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 9.60e-08 | 180 | 92 | 7 | 08ae0f5d95c45feba68ad99788f7af7ff4c979af | |
| ToppCell | 3'-Broncho-tracheal-Mesenchymal-Fibroblastic-fibroblastic_type_1-Adventitial_fibroblasts-Adventitial_fibroblasts_L.2.1.2.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.04e-07 | 182 | 92 | 7 | d179b5deb07c20d49eb6c58d5a65904f8921de3a | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.12e-07 | 184 | 92 | 7 | 2cbed6462fea2622871bb7e49b0df3d984239281 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.12e-07 | 184 | 92 | 7 | ea7a7e2bac46d4d2c31a5d576b38a032b5335062 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.12e-07 | 184 | 92 | 7 | 2b19a8c5f823e00812908b23e66bb4e563278aff | |
| ToppCell | COVID-19-Heart-Fib_2|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.16e-07 | 185 | 92 | 7 | 8f95d8e591bf7379d13f5a0545b0cb49e2b1ab5d | |
| ToppCell | COVID-19-Heart-Fib_1|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.29e-07 | 188 | 92 | 7 | fe361215f4ba841aa5e1e581fb56f2f4d3ccd201 | |
| ToppCell | LPS-IL1RA-Stromal_mesenchymal-Matrix_Fibroblast-Diff_MatrixFB|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.34e-07 | 189 | 92 | 7 | e9d5e858e320c6e9913c1ea6a54967d21eda605f | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.34e-07 | 189 | 92 | 7 | c734e5693808a0333139e87bd5be2597a9252afe | |
| ToppCell | PND01-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF2-AF2_mature|PND01 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.39e-07 | 190 | 92 | 7 | 947807863a9b247c301c6cf63d6fd5a2c8018e66 | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast-|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.39e-07 | 190 | 92 | 7 | 2e592323085ba9c019d678ac2a784462ab470ed9 | |
| ToppCell | Control-Fibroblasts|Control / group, cell type (main and fine annotations) | 1.39e-07 | 190 | 92 | 7 | 3a42a9b98d954685d38a741f44545898d0e3e9ce | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.39e-07 | 190 | 92 | 7 | 445952b70abffadb6ccc1ed4bbf61a88b06b73b3 | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast-|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.44e-07 | 191 | 92 | 7 | c54c420a94dc749ebc67fc64c5614663f4b9798d | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Mesenchymal|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.44e-07 | 191 | 92 | 7 | 806b94f567ea09a9f443cd4091e70cdb1253ac08 | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.44e-07 | 191 | 92 | 7 | cb0aee740b08f7d5fdd2717ecf7429043b277ae7 | |
| ToppCell | PND01-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF2|PND01 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.44e-07 | 191 | 92 | 7 | db4943dd19207663fb9e27f8940fa4b06a933625 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.49e-07 | 192 | 92 | 7 | 9093a9e94a25682d109a7f6edc256a25a61103a0 | |
| ToppCell | facs-Heart-LV-3m-Mesenchymal-fibroblast_of_cardiac_tissue|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.49e-07 | 192 | 92 | 7 | 671d4e1eee5aba03c43dbc98f4b51ce42b3df5d5 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast-|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.49e-07 | 192 | 92 | 7 | 9ed5d49621ec1aa01716dc369bba1450b5f015f5 | |
| ToppCell | LPS_only-Stromal_mesenchymal-Matrix_Fibroblast-Activated_MatrixFB|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.49e-07 | 192 | 92 | 7 | df1545670370fb1010c567cd059c2783eab315f7 | |
| ToppCell | LPS-IL1RA+antiTNF-Stromal_mesenchymal|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.49e-07 | 192 | 92 | 7 | 3d0cb19f037f604253d7d728689aeaa94251e92b | |
| ToppCell | facs-Heart-LV-3m-Mesenchymal-fibroblast_of_cardiac_tissue|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.49e-07 | 192 | 92 | 7 | 840a34c1b82d218be999ab5e1bcafd6370d7a4b1 | |
| ToppCell | droplet-Limb_Muscle-nan-18m-Mesenchymal|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.54e-07 | 193 | 92 | 7 | 49600db68ed65cafc67bd45a285b364e4f5f88af | |
| ToppCell | Control-Fibroblasts-Intermediate_pathological_FB|Control / group, cell type (main and fine annotations) | 1.60e-07 | 194 | 92 | 7 | 03a269f75a481ea54aea8e6444605db8d6df493d | |
| ToppCell | droplet-Heart-nan-3m-Mesenchymal-fibroblast|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.60e-07 | 194 | 92 | 7 | ce32e60bcea1b8baf496ce9050832bc8c77d8434 | |
| ToppCell | droplet-Heart-nan-3m-Mesenchymal-fibroblast_of_cardiac_tissue|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.60e-07 | 194 | 92 | 7 | a1dc157148885cc8d3685ac81a1f4e3562aeecc9 | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.60e-07 | 194 | 92 | 7 | 6e13549f697f7478b34fe71f7dd9d63c5d3db22e | |
| ToppCell | LA-02._Fibroblast_II|LA / Chamber and Cluster_Paper | 1.60e-07 | 194 | 92 | 7 | 234d1494c114cce77c619708bbcd8d5ce805f19b | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.65e-07 | 195 | 92 | 7 | d9a5c75d31c6e8bb1e1ab7fd115ac5deb5fb1c8d | |
| ToppCell | COVID-19-Heart-Fib_1|Heart / Disease (COVID-19 only), tissue and cell type | 1.65e-07 | 195 | 92 | 7 | f423baa36ac7cdc383c033e35a7d17e6bf913323 | |
| ToppCell | COVID-19-Fibroblasts-Alveolar_FB|COVID-19 / group, cell type (main and fine annotations) | 1.65e-07 | 195 | 92 | 7 | 603050beeb33c331d4b2e3fa46cae3f3e0e4bdc7 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.65e-07 | 195 | 92 | 7 | 44d7bef5f59c2c2bad1392ee6aabdaa5d7f531d9 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast-|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.71e-07 | 196 | 92 | 7 | a12dd986df65c36f248cf10815c3b8b6238613b0 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.71e-07 | 196 | 92 | 7 | ba869f7a86f37fd6d84d6ad69baca0e0faaf5887 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast-|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.71e-07 | 196 | 92 | 7 | 30ad56d49000e4ddce73b4443b3994564bd1e2d6 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.71e-07 | 196 | 92 | 7 | 3e6803587d8566fd08cb8b290be3b6461743d79c | |
| ToppCell | Children_(3_yrs)-Mesenchymal|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.71e-07 | 196 | 92 | 7 | bc94909f9b2dc08a59eef1914148b69720569c8f | |
| ToppCell | LPS_anti-TNF-Mesenchymal_fibroblastic-Fibroblasts-Activated_MatrixFB|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 1.77e-07 | 197 | 92 | 7 | fdb92985f7df0c280b87d3e43c2394e70786a2c7 | |
| ToppCell | COVID-19-Fibroblasts-Intermediate_pathological_FB|COVID-19 / group, cell type (main and fine annotations) | 1.77e-07 | 197 | 92 | 7 | f1c8936986123a3151140c374fcd62d6705c530b | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.77e-07 | 197 | 92 | 7 | 6d027119a5f7ca2aac1b10837e43f9a2bb54db85 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.77e-07 | 197 | 92 | 7 | b349f8e96d61a4c296af64711e11fc44459a9413 | |
| ToppCell | Parenchymal-NucSeq-Stromal-Fibroblastic-Fibro_peribronchial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.77e-07 | 197 | 92 | 7 | 44673c38384453207871d3fd8e8ba9093cc06bc5 | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.77e-07 | 197 | 92 | 7 | 4cf4e9553397cd8dee883dbec24f41bec41aff99 | |
| ToppCell | COVID-19-Fibroblasts|COVID-19 / group, cell type (main and fine annotations) | 1.77e-07 | 197 | 92 | 7 | fb847f2277609c31fffcdf49517243ce0684facf | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast-|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.77e-07 | 197 | 92 | 7 | c2e390653d5dee7e731c1840cfdab41987dede9b | |
| ToppCell | COVID-19-lung-Fibroblast|lung / Disease (COVID-19 only), tissue and cell type | 1.84e-07 | 198 | 92 | 7 | df3de77216f5c5d6141ec44d01c56b942f611838 | |
| ToppCell | Fetal_29-31_weeks|World / Lineage, Cell type, age group and donor | 1.90e-07 | 199 | 92 | 7 | 5b9d355795dd03a22f0961dfd143425c367a4654 | |
| ToppCell | Fibroblasts|World / Immune cells in Rheumatoid Arthritis Joint Synovial Tissues | 1.90e-07 | 199 | 92 | 7 | 40de6d4a31cf22efa2864f79e4ec8e2b7bfc9d4a | |
| ToppCell | 343B-Fibroblasts-Fibroblast-F|343B / Donor, Lineage, Cell class and subclass (all cells) | 1.90e-07 | 199 | 92 | 7 | b877c1d24357249781032e99d4237f72789cc9b8 | |
| ToppCell | Fibroblasts-CD34+_Fibroblasts|World / Immune cells in Rheumatoid Arthritis Joint Synovial Tissues | 1.90e-07 | 199 | 92 | 7 | 13ff7409e200a0b46cdb7924d15ef33639693622 | |
| ToppCell | 3'-Pediatric_IBD-SmallIntestine-Mesenchymal-fibroblastic-Stromal_1_(ADAMDEC1+)|Pediatric_IBD / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.90e-07 | 199 | 92 | 7 | 6139687a3a5025cb98da4dba0183f95fcae3dc61 | |
| ToppCell | LPS_IL1RA-Mesenchymal_fibroblastic-Fibroblasts-Activated_MatrixFB|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 1.90e-07 | 199 | 92 | 7 | 8b86c69aaf60feff53aa782559cfece7342a23de | |
| ToppCell | 343B-Fibroblasts-Fibroblast-F-|343B / Donor, Lineage, Cell class and subclass (all cells) | 1.90e-07 | 199 | 92 | 7 | e32fa66f3361474088ba1dd58574822537950d59 | |
| ToppCell | ILEUM-non-inflamed-(8)_Fibroblast-(8)_Fibroblasts|(8)_Fibroblast / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 1.90e-07 | 199 | 92 | 7 | 56d72da6a5fab9cbb2975fe6f87a631debaba6a8 | |
| ToppCell | LPS_anti-TNF-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 1.96e-07 | 200 | 92 | 7 | 9b0916d8d07ac2bf1739f7be5296bf77ffee6094 | |
| ToppCell | Bronchial-NucSeq-Stromal-Fibroblastic-Fibro_adventitial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.96e-07 | 200 | 92 | 7 | ad3fdcef895400f929f2ae12ff9bd85fd46adb3a | |
| ToppCell | Bronchial-NucSeq-Stromal|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.96e-07 | 200 | 92 | 7 | 389cc775c8419d90fb77cd794376d2160a7bf44e | |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport-2m-Neuroepithelial|2m / Sample Type, Dataset, Time_group, and Cell type. | 1.96e-07 | 200 | 92 | 7 | 3da9441c0f1e242f0d195de47ecd4c24dfdca232 | |
| ToppCell | metastatic_Brain-Fibroblasts-FB-like_cells|Fibroblasts / Location, Cell class and cell subclass | 1.96e-07 | 200 | 92 | 7 | f62833c63f9c6a94b6cc2ba8e2f960e67f093f48 | |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport-2m-Neuroepithelial-Proteoglycan-expressing_cell|2m / Sample Type, Dataset, Time_group, and Cell type. | 1.96e-07 | 200 | 92 | 7 | eed2bafddcd041ef5fcc4d1d31edb8be4d83ce01 | |
| ToppCell | LPS_IL1RA_TNF-Mesenchymal_fibroblastic-Fibroblasts|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 1.96e-07 | 200 | 92 | 7 | 44a68bacdb3d5bf563bd35952176995850933a81 | |
| ToppCell | Tracheal-NucSeq-Stromal|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.96e-07 | 200 | 92 | 7 | c318d14bd6fd6f42c597eb55ac9e2f48008aeb9b | |
| ToppCell | Tracheal-10x3prime_v2-Stromal-Fibroblastic-Fibro_adventitial|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 1.96e-07 | 200 | 92 | 7 | 9dd2eb70c1cc146935f5aff27373dfc65cb8c098 | |
| ToppCell | LPS_only-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB|LPS_only / Treatment groups by lineage, cell group, cell type | 1.96e-07 | 200 | 92 | 7 | a7ef7022b8efcaedb7319b0b43d8c4e99d788fe2 | |
| ToppCell | LPS_IL1RA_TNF-Mesenchymal_fibroblastic|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 1.96e-07 | 200 | 92 | 7 | dc61016c61729f69649cfb21f6264e685ce83dea | |
| ToppCell | BALF-PFMC-Severe-critical_progression_d12-22_with-steroid-Myeloid-Granulocytic-Neutrophil-Neu_c1-IL1B|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 9.83e-07 | 159 | 92 | 6 | fb9a45c1d596226128ce4f1adaebb066766e590a | |
| Computational | Metal / Ca ion binding. | 2.00e-05 | 133 | 46 | 6 | MODULE_324 | |
| Computational | Oxidoreductases. | 2.58e-05 | 14 | 46 | 3 | MODULE_464 | |
| Computational | DRG (dorsal root ganglia) genes. | 2.94e-05 | 384 | 46 | 9 | MODULE_2 | |
| Computational | Genes in the cancer module 194. | 3.22e-05 | 15 | 46 | 3 | MODULE_194 | |
| Computational | Spinal cord (neuro-development) genes. | 1.25e-04 | 360 | 46 | 8 | MODULE_12 | |
| Computational | ECM and collagens. | 3.66e-04 | 225 | 46 | 6 | MODULE_47 | |
| Computational | Genes upregulated in subsets of cells of a given type within various tumors | 1.25e-03 | 50 | 46 | 3 | GAVISH_3CA_METAPROGRAM_FIBROBLASTS_CAF_1 | |
| Computational | Neighborhood of CD33 | 1.40e-03 | 52 | 46 | 3 | GNF2_CD33 | |
| Computational | Trachea genes. | 1.77e-03 | 415 | 46 | 7 | MODULE_6 | |
| Drug | Cinnarizine | 2.83e-08 | 9 | 90 | 4 | DB00568 | |
| Drug | Nimodipine | 2.83e-08 | 9 | 90 | 4 | DB00393 | |
| Drug | Mibefradil | 7.38e-08 | 11 | 90 | 4 | DB01388 | |
| Drug | CNS 1145 | 1.88e-07 | 33 | 90 | 5 | CID000190902 | |
| Drug | IHC-64 | 1.88e-07 | 33 | 90 | 5 | CID000162753 | |
| Drug | FPL 64176 | 3.01e-07 | 15 | 90 | 4 | CID000003423 | |
| Drug | AC1L2AC7 | 3.16e-07 | 69 | 90 | 6 | CID000068733 | |
| Drug | Verapamil | 4.01e-07 | 16 | 90 | 4 | DB00661 | |
| Drug | Nisoldipine | 5.94e-07 | 5 | 90 | 3 | DB00401 | |
| Drug | Nilvadipine | 5.94e-07 | 5 | 90 | 3 | DB06712 | |
| Drug | 2,3-pentanedione | 8.05e-07 | 129 | 90 | 7 | ctd:C013186 | |
| Drug | CPU-23 | 1.18e-06 | 6 | 90 | 3 | CID003036051 | |
| Drug | Amlodipine | 2.07e-06 | 7 | 90 | 3 | DB00381 | |
| Drug | Isradipine | 2.07e-06 | 7 | 90 | 3 | DB00270 | |
| Drug | 3-butynoate | 2.07e-06 | 7 | 90 | 3 | CID000137547 | |
| Drug | 3-butynal | 2.07e-06 | 7 | 90 | 3 | CID000142966 | |
| Drug | manidipine | 2.11e-06 | 95 | 90 | 6 | CID000004008 | |
| Drug | desmosine | 2.13e-06 | 53 | 90 | 5 | CID000025435 | |
| Drug | Cinildipine | 2.81e-06 | 56 | 90 | 5 | CID000002752 | |
| Drug | Nifedipine | 3.30e-06 | 8 | 90 | 3 | DB01115 | |
| Drug | C04554 | 3.30e-06 | 8 | 90 | 3 | CID000440384 | |
| Drug | Nitrendipine | 3.30e-06 | 8 | 90 | 3 | DB01054 | |
| Drug | loperamide | 3.79e-06 | 105 | 90 | 6 | CID000003954 | |
| Drug | nilvadipine | 3.97e-06 | 60 | 90 | 5 | CID000004494 | |
| Drug | IAA-94 | 4.31e-06 | 61 | 90 | 5 | CID000003667 | |
| Drug | Rgd Peptide | 4.85e-06 | 239 | 90 | 8 | CID000104802 | |
| Drug | CPD 30 | 4.93e-06 | 9 | 90 | 3 | CID000440850 | |
| Drug | 4-acetamidobutyrate | 4.93e-06 | 9 | 90 | 3 | CID000018189 | |
| Drug | lercanidipine | 5.06e-06 | 63 | 90 | 5 | CID000065866 | |
| Drug | 3-aminopropanal | 5.78e-06 | 30 | 90 | 4 | CID000000075 | |
| Drug | papaverine | 6.37e-06 | 176 | 90 | 7 | CID000004680 | |
| Drug | decanal | 6.62e-06 | 31 | 90 | 4 | CID000008175 | |
| Drug | gallopamil | 6.87e-06 | 67 | 90 | 5 | CID000001234 | |
| Drug | betaine aldehyde | 7.54e-06 | 32 | 90 | 4 | CID000000249 | |
| Drug | isodesmosine | 8.56e-06 | 33 | 90 | 4 | CID000013811 | |
| Drug | Felodipine | 9.63e-06 | 11 | 90 | 3 | DB01023 | |
| Drug | ynoate | 9.63e-06 | 11 | 90 | 3 | CID000010110 | |
| Drug | CAS 298-57-7 | 1.05e-05 | 73 | 90 | 5 | CID000002761 | |
| Drug | ethosuximide | 1.12e-05 | 74 | 90 | 5 | CID000003291 | |
| Drug | Gibberellic acid [77-06-5]; Down 200; 11.6uM; PC3; HT_HG-U133A | 1.24e-05 | 195 | 90 | 7 | 4234_DN | |
| Drug | Amethopterin (R,S) [59-05-2]; Down 200; 8.8uM; PC3; HT_HG-U133A | 1.24e-05 | 195 | 90 | 7 | 6654_DN | |
| Drug | imidazole acetaldehyde | 1.28e-05 | 12 | 90 | 3 | CID000150841 | |
| Drug | Dehydroisoandosterone 3-acetate [853-23-6]; Down 200; 12.2uM; PC3; HT_HG-U133A | 1.29e-05 | 196 | 90 | 7 | 6673_DN | |
| Drug | octanal | 1.36e-05 | 37 | 90 | 4 | CID000000454 | |
| Drug | nisoldipine | 1.45e-05 | 78 | 90 | 5 | CID000004499 | |
| Drug | N-cyclopentyl-N-cyclobutylformamide | 1.54e-05 | 79 | 90 | 5 | CID005287890 | |
| Drug | AC1L1JG6 | 2.11e-05 | 14 | 90 | 3 | CID000005026 | |
| Drug | 6-[(3R,7R)-3,7-dihydroxy-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl]-2-methylheptanal | 2.63e-05 | 15 | 90 | 3 | CID000440673 | |
| Drug | glycurone | 3.22e-05 | 16 | 90 | 3 | CID000003483 | |
| Drug | hexanal | 3.58e-05 | 47 | 90 | 4 | CID000006184 | |
| Drug | trimethylaminobutyraldehyde | 3.90e-05 | 17 | 90 | 3 | CID000000133 | |
| Drug | propynal | 3.90e-05 | 17 | 90 | 3 | CID000012222 | |
| Drug | isotetrandrine | 4.18e-05 | 97 | 90 | 5 | CID000005422 | |
| Drug | funiferine N-oxide | 4.22e-05 | 49 | 90 | 4 | CID000191631 | |
| Drug | nitrendipine | 4.39e-05 | 98 | 90 | 5 | CID000004507 | |
| Drug | KW-3049 | 4.58e-05 | 50 | 90 | 4 | CID000002324 | |
| Drug | decanaldehyde | 4.62e-05 | 3 | 90 | 2 | ctd:C021170 | |
| Drug | Benzaldehydes | 4.62e-05 | 3 | 90 | 2 | ctd:D001547 | |
| Drug | isradipine | 4.83e-05 | 100 | 90 | 5 | CID000003784 | |
| Drug | propionaldehyde | 4.95e-05 | 51 | 90 | 4 | CID000000527 | |
| Drug | 5-HIAL | 5.53e-05 | 19 | 90 | 3 | CID000074688 | |
| Drug | felodipine | 5.69e-05 | 169 | 90 | 6 | CID000003333 | |
| Drug | quinocetone | 5.79e-05 | 248 | 90 | 7 | ctd:C502851 | |
| Drug | perillaldehyde | 7.54e-05 | 21 | 90 | 3 | CID000016441 | |
| Drug | NSC-686960 | 9.22e-05 | 4 | 90 | 2 | CID000192816 | |
| Drug | benzaldehyde | 9.40e-05 | 60 | 90 | 4 | CID000000240 | |
| Drug | lamotrigine | 9.80e-05 | 116 | 90 | 5 | CID000003878 | |
| Drug | DEAB | 9.99e-05 | 23 | 90 | 3 | CID000056566 | |
| Drug | AC1NBU2S | 1.02e-04 | 117 | 90 | 5 | CID004473765 | |
| Drug | gamma-aminobutyric acid | CACNA1C CACNA1D CACNA1F CACNA1S ALDH2 ALDH1A3 ALDH9A1 RYR2 RIT2 | 1.08e-04 | 474 | 90 | 9 | CID000000119 |
| Drug | indole-3-acetyl-l-valine | 1.29e-04 | 65 | 90 | 4 | CID000446641 | |
| Drug | Ampyrone [83-07-8]; Up 200; 19.6uM; MCF7; HT_HG-U133A | 1.29e-04 | 196 | 90 | 6 | 6845_UP | |
| Drug | gamma-aminobutyraldehyde | 1.29e-04 | 25 | 90 | 3 | CID000000118 | |
| Drug | Althiazide [5588-16-9]; Up 200; 10.4uM; MCF7; HT_HG-U133A | 1.32e-04 | 197 | 90 | 6 | 6829_UP | |
| Drug | Dimenhydrinate [523-87-5]; Up 200; 8.6uM; MCF7; HT_HG-U133A | 1.32e-04 | 197 | 90 | 6 | 5450_UP | |
| Drug | LY 294002; Up 200; 0.1uM; MCF7; HT_HG-U133A | 1.36e-04 | 198 | 90 | 6 | 6976_UP | |
| Drug | gadolinium | 1.40e-04 | 199 | 90 | 6 | CID000023982 | |
| Drug | Spironolactone [52-01-7]; Down 200; 9.6uM; PC3; HT_HG-U133A | 1.40e-04 | 199 | 90 | 6 | 5781_DN | |
| Drug | bepridil | 1.45e-04 | 126 | 90 | 5 | CID000002351 | |
| Drug | pimozide | 1.50e-04 | 127 | 90 | 5 | CID000016362 | |
| Drug | B 874-67 | 1.53e-04 | 5 | 90 | 2 | CID000195466 | |
| Drug | nemadipine-A | 1.53e-04 | 5 | 90 | 2 | CID002856102 | |
| Drug | n-butoxyacetaldehyde | 1.53e-04 | 5 | 90 | 2 | ctd:C053320 | |
| Drug | methyl beta-aminocrotonate | 1.53e-04 | 5 | 90 | 2 | CID000084253 | |
| Drug | succinic semialdehyde | 1.62e-04 | 69 | 90 | 4 | CID000001112 | |
| Drug | aldosterone | 1.78e-04 | 397 | 90 | 8 | CID000005839 | |
| Drug | indole-3-acetaldehyde | 1.82e-04 | 28 | 90 | 3 | CID000000800 | |
| Drug | monatepil | 2.03e-04 | 29 | 90 | 3 | CID000060810 | |
| Drug | lanthanum | 2.07e-04 | 136 | 90 | 5 | CID000023926 | |
| Drug | 8-bromoguanosine 3',5'-cyclic monophosphate | 2.22e-04 | 308 | 90 | 7 | CID000001915 | |
| Drug | 3,4-dihydroxyphenylacetaldehyde | 2.24e-04 | 30 | 90 | 3 | CID000119219 | |
| Drug | chloro-m-cresol | 2.29e-04 | 6 | 90 | 2 | CID000012008 | |
| Drug | Magnesium Sulfate | 2.29e-04 | 6 | 90 | 2 | DB00653 | |
| Drug | NSC114784 | 2.29e-04 | 6 | 90 | 2 | CID000419425 | |
| Drug | 4-(N,N-dipropylamino)benzaldehyde | 2.29e-04 | 6 | 90 | 2 | CID000069171 | |
| Drug | glyceraldehyde | 2.36e-04 | 140 | 90 | 5 | CID000000751 | |
| Drug | perillic acid | 2.48e-04 | 31 | 90 | 3 | CID000001256 | |
| Drug | methylmalonate semialdehyde | 2.73e-04 | 32 | 90 | 3 | CID000000296 | |
| Drug | nimodipine | 2.78e-04 | 145 | 90 | 5 | CID000004497 | |
| Drug | nicardipine | 2.78e-04 | 145 | 90 | 5 | CID000004473 | |
| Disease | Timothy syndrome (implicated_via_orthology) | 5.54e-11 | 4 | 82 | 4 | DOID:0060173 (implicated_via_orthology) | |
| Disease | connective tissue disease (implicated_via_orthology) | 2.07e-08 | 3 | 82 | 3 | DOID:65 (implicated_via_orthology) | |
| Disease | Duchenne muscular dystrophy (implicated_via_orthology) | 3.05e-06 | 36 | 82 | 4 | DOID:11723 (implicated_via_orthology) | |
| Disease | carpal tunnel syndrome | 5.06e-06 | 89 | 82 | 5 | EFO_0004143 | |
| Disease | Niemann-Pick Disease, Type C1 | 7.63e-06 | 2 | 82 | 2 | C3179455 | |
| Disease | Niemann-Pick Disease, Type D | 7.63e-06 | 2 | 82 | 2 | C0268247 | |
| Disease | Niemann-Pick Disease, Type C | 7.63e-06 | 2 | 82 | 2 | C0220756 | |
| Disease | macula measurement | 1.49e-05 | 189 | 82 | 6 | EFO_0008375 | |
| Disease | glomerulonephritis (biomarker_via_orthology) | 2.28e-05 | 20 | 82 | 3 | DOID:2921 (biomarker_via_orthology) | |
| Disease | scoliosis (is_implicated_in) | 4.56e-05 | 4 | 82 | 2 | DOID:0060249 (is_implicated_in) | |
| Disease | brain infarction (is_implicated_in) | 7.59e-05 | 5 | 82 | 2 | DOID:3454 (is_implicated_in) | |
| Disease | Abnormality of refraction | 1.05e-04 | 673 | 82 | 9 | HP_0000539 | |
| Disease | corneal resistance factor | 2.64e-04 | 451 | 82 | 7 | EFO_0010067 | |
| Disease | Mental deterioration | 2.71e-04 | 9 | 82 | 2 | C0234985 | |
| Disease | Mild cognitive disorder | 2.71e-04 | 9 | 82 | 2 | C1270972 | |
| Disease | centronuclear myopathy X-linked (implicated_via_orthology) | 2.71e-04 | 9 | 82 | 2 | DOID:0111225 (implicated_via_orthology) | |
| Disease | ocular sarcoidosis | 3.13e-04 | 116 | 82 | 4 | EFO_0010723 | |
| Disease | cortical surface area measurement | ALDH1A2 FBN1 FBN2 STAG1 KIF26B VCAN LAMC3 FBN3 MOV10 LRP8 DNAH11 RIT2 | 3.31e-04 | 1345 | 82 | 12 | EFO_0010736 |
| Disease | aortic aneurysm | 3.38e-04 | 10 | 82 | 2 | EFO_0001666 | |
| Disease | blood copper measurement | 3.69e-04 | 50 | 82 | 3 | EFO_0007578 | |
| Disease | Sensory hearing loss | 4.13e-04 | 11 | 82 | 2 | C1691779 | |
| Disease | Familial thoracic aortic aneurysm and aortic dissection | 4.38e-04 | 53 | 82 | 3 | C4707243 | |
| Disease | coronary artery disease | NPC1 COL4A4 LIPA ALDH1A2 FBN2 STAG1 CRYGN LRP1 LAMB2 ALDH2 ADGRL3 | 4.58e-04 | 1194 | 82 | 11 | EFO_0001645 |
| Disease | Alzheimer's disease (is_implicated_in) | 5.11e-04 | 132 | 82 | 4 | DOID:10652 (is_implicated_in) | |
| Disease | Impaired cognition | 6.79e-04 | 14 | 82 | 2 | C0338656 | |
| Disease | aspartate aminotransferase measurement | OR2B11 CACNA1S TMEM171 LIPA CROT ALDH1A2 ALDH2 SEPTIN10 MOV10 | 9.07e-04 | 904 | 82 | 9 | EFO_0004736 |
| Disease | Limb Deformities, Congenital | 1.01e-03 | 17 | 82 | 2 | C0206762 | |
| Disease | risk-taking behaviour | 1.29e-03 | 764 | 82 | 8 | EFO_0008579 | |
| Disease | exercise test | 1.40e-03 | 20 | 82 | 2 | EFO_0004328 | |
| Disease | carotid artery intima media thickness | 1.60e-03 | 450 | 82 | 6 | EFO_0007117 | |
| Disease | Sensorineural Hearing Loss (disorder) | 1.86e-03 | 23 | 82 | 2 | C0018784 | |
| Disease | descending aortic diameter | 1.91e-03 | 88 | 82 | 3 | EFO_0021788 | |
| Disease | HMG CoA reductase inhibitor use measurement | 1.93e-03 | 189 | 82 | 4 | EFO_0009932 | |
| Disease | Charcot-Marie-Tooth disease (implicated_via_orthology) | 2.02e-03 | 24 | 82 | 2 | DOID:10595 (implicated_via_orthology) | |
| Disease | Ischemic stroke | 2.12e-03 | 324 | 82 | 5 | HP_0002140 | |
| Disease | Bipolar Disorder | 2.15e-03 | 477 | 82 | 6 | C0005586 | |
| Disease | gout | 2.20e-03 | 196 | 82 | 4 | EFO_0004274 | |
| Disease | pseudotumor cerebri | 2.37e-03 | 26 | 82 | 2 | EFO_1001132 | |
| Disease | PR interval | 2.58e-03 | 495 | 82 | 6 | EFO_0004462 | |
| Disease | optic disc size measurement | 2.59e-03 | 205 | 82 | 4 | EFO_0004832 | |
| Disease | myocardial infarction (is_implicated_in) | 2.68e-03 | 99 | 82 | 3 | DOID:5844 (is_implicated_in) | |
| Disease | mean arterial pressure | 2.69e-03 | 499 | 82 | 6 | EFO_0006340 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| FLTQGQVCCNGTRVF | 281 | P49189 | |
| GCCFRNGGSESLFRQ | 11 | A8MXV6 | |
| CRNGATCVDGFNTFR | 3136 | P13611 | |
| GVFFNQGQCCTAGSR | 311 | O94788 | |
| ICIFTFCFFRGLQSD | 881 | Q9HAR2 | |
| VFFNQGQCCTAASRV | 306 | P47895 | |
| FLECQGRQGTCHFFA | 1631 | P53420 | |
| LGTIICEAFFNCNGL | 551 | Q96DT5 | |
| FLNVCIFICGEAVQG | 11 | Q86XS5 | |
| RCTCRQGFAGDGFFC | 1346 | Q75N90 | |
| FVRGICTRFCGTSFF | 111 | Q9NV06 | |
| QCRFDFGSGYQTCLA | 481 | Q8WXS8 | |
| NFQGLRSFGCRFGTC | 101 | P35318 | |
| CLFGTFLCNCEQQRF | 536 | Q13613 | |
| ISFAGCLCQFFFSAG | 91 | Q8NH87 | |
| GCALQFLVFCIFADS | 96 | Q8NH69 | |
| SFFNRFDCFVVCGGI | 591 | O60840 | |
| VITFDGQRFVFDGNC | 876 | Q6W4X9 | |
| LSFCGNNEINFIFCD | 166 | Q8NGE9 | |
| CCGIQTLDFGAFLAQ | 186 | Q9UKP3 | |
| ICVCGRFCLNSFIQG | 356 | Q96L50 | |
| NLQCFNGGSCFLNAR | 4201 | Q07954 | |
| IQSVVNGADGCVFCF | 531 | Q2KJY2 | |
| DNTAGSFRCLCYQGF | 1261 | Q14766 | |
| GFALYFLGECNNSLC | 111 | Q9Y233 | |
| NQGCARDAFRVFCNF | 1591 | P13942 | |
| GFLCDCTIVIGEFQF | 21 | Q9NPC7 | |
| LSRCFELNTFSFCGN | 376 | P0DUQ1 | |
| GTRCQQCRDGFFGLS | 446 | P55268 | |
| FSCFVCIGQVVFALG | 116 | Q9H3U5 | |
| RFCRLGQFQCSDGNC | 3551 | P98164 | |
| PQFQGDNRCFLFSIC | 316 | Q6P9B6 | |
| ISFAGCLCQFFFSAG | 91 | P0C7N8 | |
| ARCSFNGDFVCGQCV | 466 | P16144 | |
| RLEIFEGCNFTGQCL | 96 | Q8WXF5 | |
| QLFFFLGFACTNCLL | 101 | Q8NGX3 | |
| PFCGRQVLNNFFCEV | 171 | Q5JQS5 | |
| RISLAGCGAQLFFSC | 106 | Q8NGQ1 | |
| FFFGNVSLCCDVRQL | 66 | O15118 | |
| CSINETCFNIQGGFR | 536 | P23142 | |
| TCFNIQGGFRCLAFE | 541 | P23142 | |
| GCLSQIFFFTSFGCL | 96 | O76099 | |
| CGLQRECIFQFTGNF | 106 | Q7L622 | |
| NAGVFFFRCTICNNS | 181 | Q7L622 | |
| SLFNRFDCFVVCGGI | 586 | Q13936 | |
| FNRFDCFVVCSGILE | 496 | Q13698 | |
| GSFTCECQRGFSLDQ | 2546 | P35555 | |
| RLGQCGADACFFTIN | 96 | Q6P4F1 | |
| LCCAGDAQAFGENRF | 176 | O75508 | |
| SGCLGDTQFCFRFRQ | 106 | Q8IWF6 | |
| AAFCRACQTPNFVRG | 46 | Q96EH3 | |
| CFLTGVFSQGGQVDC | 16 | Q6UWN8 | |
| DQGFALNFTCRCLVG | 151 | Q6UY11 | |
| LQFCFFRENQVLGSG | 141 | Q96LA5 | |
| FGQVCRNGRCFNEIG | 1981 | P35556 | |
| CLAAEGFGNRLCFLE | 36 | Q92736 | |
| LFNRFDCFVVCGGIT | 586 | Q01668 | |
| GCARDSFRVFCNFTA | 1566 | P25940 | |
| EFQCGNRSCLAAVFV | 171 | Q14114 | |
| CLFGTFLCNNAKERG | 511 | Q13615 | |
| YNLISFSNGVFGCNC | 311 | Q9UKG9 | |
| GCLTQIFFFIAFGCL | 96 | O60412 | |
| TFGCGYLNDFNTACL | 476 | Q5T160 | |
| DEFGFQCQNGVCISL | 1326 | Q92673 | |
| SCRQLREAGQCFESF | 6 | Q9HCE1 | |
| LFLFLCQQVASFCRG | 951 | O95255 | |
| NCGFFETSAALRFCI | 156 | Q99578 | |
| LSRCFELNTFSFCGN | 376 | A6NGN4 | |
| LSRCFELNAFSFCGN | 376 | A3QJZ7 | |
| SVSQGFCFNILCVGE | 36 | Q14141 | |
| CCRFFGDNGLTLKVF | 136 | Q8IY50 | |
| LFFNQGQCCCAGSRT | 311 | P05091 | |
| LSRCFELNTFSFCGN | 376 | O60810 | |
| RCFELNTFSFCGNPI | 376 | Q5VXH4 | |
| FRGVQCTDSRDGFQC | 296 | P35443 | |
| GQLFNNLGLCCFYAQ | 386 | Q8TAM2 | |
| GERPFQCNFCERCFT | 376 | P0CG00 | |
| MQNLADFFQCGCFGL | 581 | Q8IUH4 | |
| LSRCFELNTFSFCGN | 376 | P0DUQ2 | |
| FQGSFCEFVGTLVCR | 46 | Q8TBR4 | |
| RCFELNTFSFCGNPI | 376 | Q5TYX0 | |
| ARACGRFFQKGQGTC | 191 | Q9Y5S1 | |
| LSRCFELNTFSFCGN | 376 | O60813 | |
| INFFIQCSGCRGTVR | 121 | Q8WVM7 | |
| ELRCVFNGNAGACRF | 56 | O43761 | |
| FICGESRQFAQCLIF | 101 | Q8WVE6 | |
| IQQGFCFNILCVGET | 61 | Q9P0V9 | |
| NSSAVNVGFCFVCAR | 856 | Q9BZ95 | |
| NVGFCFVCARGLIVQ | 861 | Q9BZ95 | |
| RGRQFFKCNGGSCNF | 831 | Q13472 | |
| VFRFFGGKTLLNCCD | 361 | Q5GH77 | |
| LLTGQCDFGSNCRFS | 61 | Q9UDW3 | |
| RGDCFFQLGNLAFAE | 371 | Q8NEE8 | |
| GGNNFICSCEFLSFT | 531 | O60603 | |
| GVTGQACDRCQLGFF | 941 | Q9Y6N6 | |
| ACDRCQLGFFGFSIK | 946 | Q9Y6N6 | |
| LCGNLCFLLCGFNER | 256 | P38571 | |
| FACAECGQSFRQRSN | 541 | P28698 |